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Abbreviation 
AIMS   Anesthesia Information Management System 
ASA   American Society of Anesthesiologists physical status classification  
    system 
bpm   beats per minute 
CI   Confidence Interval  
CPR   Cardiopulmonary Resuscitation 
CV   Coefficient of variation  
EBL   Estimated blood loss 
ECG   Electrocardiography 
EDW   Vanderbilt Enterprise Data Warehouse 
HR   Heart Rate 
ICU   Intensive Care Unit 
ICD 9   International Classification of Diseases 9th Revision 
MAP   Mean arterial pressure  
NT-proBNP  N-terminal pro brain natriuretic peptide   
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PDW   Perioperative Data Warehouse  
POSSUM Physiologic and Operative Severity Score for the enUmeration of 
Mortality and Morbidity 
RCRI   Revised Cardiac Risk Index 
ROC curve  Receiver operating curve 
sAs   surgical Apgar score 
SQL   Structured Query Language 
VPIMS   Vanderbilt perioperative Information Management System database 
WHO   World Health Organization 
 
1 Introduction 
1.1 Significance of surgical risk scores 
Concurrently, the number of surgeries performed worldwide has dramatically increased.(1)Not surprising, 
patients suffering from chronic disease are more likely to undergo surgery and yet they are also at highest 
risk for post-operative complications and death.(1) Given the increasing proportion of patients with 
significant comorbidities undergoing surgery, awareness of post-operative complications and mortality 
associated with their chronic disease states should be heightened and these concerns should be viewed as 
a global public health priority. (2) Over the past years much attention has been given to the human failure 
within the surgical team but most patients faced major complications or death due to their 
comorbidities.(1) An individual risk assessment would benefit the patient, as medical treatment plans and 
intensified medical care if necessary could be applied accordingly suited to the patient’s individual needs. 
(3) So far most clinician’s rely more often on their intuition than on objective risk assessment tool. A study 
conducted in 2005 showed that surgeons underestimated the risk of complications for emergency cases in 
general surgery. On the other hand they tend to over predict the mortality and morbidity rates for elective 
surgeries in general surgery. (4) A previous study has argued that the surgeon’s “gut-feeling” is a good 
predictor of postoperative morbidity, especially when the patient was doing well.(5) Hartley et al. argued 
that surgeons are more likely to be more pessimistic about their patient’s outcome, which leads to more 
caution in the postoperative care.(5) Nevertheless, the surgeon’s prediction is influenced by many different 
variables, such as pre- and intraoperative factors and the physician’s clinical experience.(5) 
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A combination of the doctors’ clinical assessment and applying an objective risk score might be the best 
reliable predictor for a patient’s outcome. Today risk scores are necessary more than ever, as more 
complicated procedures are performed on sicker patients. (6) 
 
1.2 Surgical risk scores 
Since early identification of high-risk patients and prompt, appropriate intervention aimed at improving 
patient outcome can reduce the length of hospital stay,(7) morbidity, and mortality, (8-10) multiple risk 
scores have been designed to identify vulnerable patient populations’ pre-and post-operatively. (8-11)  
In the following chapters the most commonly applied risk scores in surgical patients will be discussed, 
such as the American Society of Anesthesiologists physical status classification system(12) (ASA 
classification), the physiologic and Operative Severity Score for the enUmeration of Mortality and 
Morbidity (POSSUM)(13), the revised cardiac risk index (RCRI)(14), and the surgical Apgar score (sAs)(8). 
The American Society of Anesthesiologists classification is commonly used as a preoperative risk 
assessment of the patients’ current health status.(15, 16) The RCRI predicts cardiac risk in non-cardiac 
surgeries and is commonly used in various surgical fields.(11) The POSSUM score was intended for 
surgical audit purposes but is also widely applied as a surgical risk assessment.(13, 17) However, most of 
these risk scores are based on rather complicates algorithms consisting of numerous variables, and are not 
easily applicable at the patient’s bedside.(11) Each risk score has many benefits but also several limitations 
which will be discussed in detail within each section.  
In 2007 Gawande et al. developed the surgical Apgar score, a simple ten-point scoring system.(8) End-of-
case surgical Apgar score provides clinicians with useful and important information about patients’ 
postoperative risk for major complications.(18) The score distinguishes between patients with high and low 
risk for adverse events and serves as a decision-support tool.(19) 
We hypothesize that continuous monitoring of sAs trends may provide additional information about 
changes in a patient’s risk for complications and may exhibit greater predictive ability about a patient’s 
post-operative morbidity and mortality.   
1.2.1 American Society of Anesthesiologists physical status classification system 
1.2.1.1 Background 
The ASA classification of Physical Status was first introduced in 1941 by Saklad for retrospective 
analysis of hospital records, classifying patients into seven categories.(12) In 1961 an alteration of the 
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classification was proposed by Dripps et al.(20) and the new classification was modified to five classes 
with the approval of the American Society of Anesthesiologists in 1963.(21) The classification is based on 
the past medical history and a preoperative examination of the patient(22) : 
ASA Physical Status I - A normal healthy patient 
ASA Physical Status II - A patient with mild systemic disease 
ASA Physical Status III - A patient with severe systemic disease 
ASA Physical Status IV - A patient with severe systemic disease that is a constant threat to life 
ASA Physical Status V - A moribund patient who is not expected to survive without the operation                                                     
ASA Physical Status VI - A declared brain-dead patient whose organs are being removed for donor    
purposes(22) 
The patient is allocated to one of the six categories. The letter E behind the Roman numbers classifies an 
emergency case and the patient is therefore considered to be in a poorer condition. (22)  
1.2.1.2 Application 
Initially the ASA classification served as a description of the patient’s physical status. However it was 
widely adapted and used as an individual surgical risk predictor for morbidity and mortality. (15, 23) 
A study which was conducted in five different teaching hospitals in the United States demonstrated that a 
higher class in ASA physical status is associated with prolonged length of hospital stay, complications, 
and more follow-up visits at physicians after discharge.(24) Cullen et al. proposed to combine the ASA 
classification with age in order to equally use resources among patients. The adapted ASA classification 
might predict follow-up visits, the patient’s risk for adverse events, and hospital length of stay more 
accurately.(24) However age was not incorporated in the commonly used ASA classification. It was 
reported that the ASA classification reports long term mortality in patients undergoing orthopedic 
surgery.(25) In a further study four different classification systems were validated for their predictive 
ability and it was reported that the ASA classification is more predictive for major postoperative 
complications than for minor adverse events. (6) 
1.2.1.3 Benefits and limitations  
Several studies have demonstrated that a higher ASA class is associated with a higher perioperative 
mortality, morbidity and longer hospitalization. (21, 23, 26-30) Additionally, the ASA classification was found 
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to be significantly associated with intraoperative blood loss, intensive care unit stay, duration of 
postoperative ventilation, and cardiopulmonary complications.(21) As the classification is based on 
physical examination and the evaluation of the patient’s past medical history the assessment is 
inexpensive as no additional diagnostic testing is required. (21, 31) The classification system is applied in 
various medical settings, such as in hospitals, (32) outpatient clinics,(33) and researchers who investigated 
the severity of surgical procedures and its risk evaluation.(34) The common application of the ASA 
classification might be due to its simplicity and suitability for all surgical services.(35) 
Nevertheless, the simplicity of the ASA classification is double edged. On the one hand it alleviates 
communication among health care providers and enables a fast and simple application.(31) On the other 
hand its simplicity leads to discrepancy in the allocation among different physicians and inaccurate 
clinical interpretation.(22, 36) Additionally, the ASA classification does not consider the severity of the 
surgical procedure and it lacks scientific precision, (15) as the assessment does not incorporate objective 
criteria to the classification. Furthermore the assignment of an ASA class varies among physicians and is 
therefore not entirely reliable.(15, 22, 37, 38)Moreover, the commonly used classification does not incorporate 
age, weight, sex, and pregnancy.(11, 39) Aplin et colleagues discovered many variation in the ASA 
classification in children, concluding that the ASA classification is not a reliable tool in predicting 
surgical outcome in a pediatric population. (40) 
1.2.2 Revised Cardiac Risk Index 
1.2.2.1 Background 
The Revised Cardiac Risk Index (RCRI)(14), an alteration of the Goldman Index (14, 41), predicts the risk of 
major cardiac complications and cardiovascular mortality (42) in non-cardiac surgery. Major complications 
were defined as myocardial infarction, pulmonary edema, ventricular fibrillation or primary cardiac 
arrest, and complete heart block. (14) 
The Revised Cardiac Risk Index was derived from analysis of 29 variables in a cohort of 4,315 patients 
undergoing major elective non-cardiac surgery in a tertiary-care teaching hospital. The Revised Cardiac 
Risk Index is based on the following six values: 
• High-risk type of surgery (intraperitoneal, intrathoracic, or suprainguinal vascular surgery) 
• History of ischemic heart disease (history of myocardial infarction, history of positive exercise 
test, current complain of chest pain considered secondary to myocardial ischemia, use of nitrate 
therapy, ECG with pathological Q waves) 
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• History of congestive heart failure (history of congestive heart failure, pulmonary edema, 
paroxysmal nocturnal dyspnea, bilateral rales or S3 gallop, chest radiograph showing pulmonary 
vascular redistribution) 
• History of cerebrovascular disease (history of transient ischemic attack or stroke) 
• Preoperative treatment with insulin 
• Preoperative serum creatinine greater than 2.0 mg/dL(14) 
 
If two of the six criteria are met, patients with intermediate and higher risk of cardiac risk can be 
identified.(14)  
The study conducted by Lee et al. has several limitations: no neurosurgical cases and emergency cases 
were incorporated. Furthermore patients who had an anticipated hospital length of stay of less than 2 days 
were also excluded. The study was predominated by thoracic, vascular and orthopedic cases. (14, 43, 44)  
 
1.2.2.2 Application 
The Revised Cardiac Risk Index is the optimal cardiac risk score applied in non-cardiac surgery, 
according to the American College of Cardiology/American Heart Association 2007 guidelines (45) and 
European Society of Cardiology/European Society of Anesthesiology guidelines. (46) 
Due to the good predictive ability for cardiac adverse events in non-cardiac surgeries, the RCRI is the 
most commonly used cardiac risk score.(47) The RCRI has been confirmed to be applicable in numerous 
surgical procedures such as in vascular surgery and also in lung resection.(48-52)  
The revised cardiac risk index was modified and tested for its predictive ability in elective orthopedic 
surgery for non-cardiac adverse events. It was shown that the score is not a strong predictor for 
postoperative morbidity.(53) A recent study has shown the significant association between the RCRI, 
postoperative hospital length of stay and morbidity in patients undergoing elective orthopedic surgery. 
The risk for morbidity and prolonged hospitalization increased, with a modified revised cardiac risk index 
greater than three.(53) 
 
1.2.2.3 Benefits and Limitations 
 
The Revised Cardiac Risk Index is predictive for myocardial infarction and perioperative death in non-
cardiac surgery.(11, 53) 
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The index has proven to predict short and long term cardiac complications within patients undergoing 
non-cardiac surgery.(54) The RCRI is an inexpensive predictive tool derived from the past medical history, 
physical examination, and serum creatinine.(55) The index is a simple tool to identify patients, over the age 
of 50 at risk of having a cardiac complication undergoing elective non-cardiac surgery.(56) 
However, it was reported that the index is not an accurate cardiac risk predictor for patients undergoing 
vascular surgery.(57, 58) A study has shown that the predictive ability of the RCRI is decreased in patients 
over the age of 75, who undergo vascular surgery.(49) Furthermore it was described by Choi et al. that the 
Revised Cardiac Risk Index is not predicting acute myocardial infarction, pulmonary edema or 
cardiovascular death as accurately as biomarkers, such as preoperative NT-proBNP or cardiopulmonary 
resuscitation (CPR).(59) It is commonly known, that elderly patients are at an increased risk of suffering 
from cardiac adverse events and therefore cardiac risk assessment is of high importance.(49, 60, 61) The 
RCRI does not indicate which patient needs additional diagnostic investigation and therefore leads to 
extravagant cardiac testing. (62) Recent results of Lupei et al. indicated that the RCRI is not associated with 
postoperative intensive care outcomes.(63) Another limitation of the Revised Cardiac Risk Index is that it 
only predicts perioperative cardiac complications, as it is not designed to predict the overall mortality risk 
in surgical patients. (58, 64) Consequently, the score cannot predict any other surgical complication, such as 
surgical-site infection or pulmonary complications.(65) This limitation is relevant, as only 1% of all 
patients who undergo non-cardiac surgery every year suffer from cardiac complications.(44, 66) 
 
1.2.3 Physiological and Operative Severity Score for the enUmeration of Mortality and 
morbidity (POSSUM) 
1.2.3.1 Background  
The Physiological and Operative Severity Score for the enUmeration of Mortality and morbidity 
(POSSUM) was introduced by Copeland et al. in 1991 and was originally used as an operative severity 
score for general surgery in comparative surgical audit.(13) The intention of the score was to compare 
individual surgical performance and different hospitals among each other. Surgical performance is 
measured by comparing predicted negative outcome with observed outcome. Copeland and colleagues 
incorporated 48 physiologic parameters and 14 operative and postoperative factors to assess the score.(13)  
By using multivariate analysis the POSSUM was simplified.(13) The final POSSUM score incorporates 12 
physiological variables and in combination with 6 operative variables. (Table 1)(13, 67) The POSSUM score 
predicts the following complications described in Table 2.(13)  
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Table 1. POSSUM: physiological and operative parameters 
Physiological parameters      Operative parameters 
Age         Operative severity 
Cardiac signs        Multiple procedures 
Respiratory history (dyspnea)     Total blood loss 
Blood pressure        Peritoneal soiling 
Pulse rate        Presence of malignancy 
Glasgow Coma Score       Mode of surgery 
Hemoglobin level 
White cell count 
Urea concentration 
Sodium 
Potassium 
Electrocardiography 
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Table 2. Definition of POSSUM score complications 
Wound hemorrhage    local hematoma requiring evacuation 
Deep hemorrhage   postoperative bleeding requiring re-exploration 
Chest infection production of purulent sputum with positive bacteriological 
cultures, with or without chest radiography changes or pyrexia, 
or consolidation seen on chest radiograph 
 
Wound infection wound cellulites or the discharge of purulent exudate 
Urinary infection the presence of >105 bacteria/ml with the presence of white cells 
in the urine, in previously clear urine 
Deep infection the presence of an intra-abdominal collection confirmed 
clinically or radiologically 
 
Septicemia    positive blood culture 
Pyrexia of unknown origin any temperature above 37°C for more than 24 h occurring after 
the original pyrexia following surgery (if present) had settled, for 
which no obvious cause could be found 
 
Wound dehiscence   superficial or deep wound breakdown 
Deep venous thrombosis when suspected, confirmed radiologically by venography or    
and pulmonary embolus ventilation/perfusion scanning, or diagnosed at post mortem 
 
Cardiac failure symptoms or signs of left ventricular or congestive cardiac 
failure that required an alteration from preoperative therapeutic 
measures 
 
Impaired renal function  arbitrarily defined as an increase in blood urea of > 5 mmol/l 
from preoperative levels 
 
Hypotension a fall in systolic blood pressure below 90 mmHg for more than 2 
hours as determined by sphygmomanometry or arterial pressure 
transducer measurement 
 
In the original paper pediatric patients were excluded from the study, as the physiologic values are 
different than those in adults. Additionally all patients leaving the same day as their surgery, were 
excluded, as their mortality and morbidity rates were very low. (13) Cardiac signs are defined as no cardiac 
failure, diuretic, digoxin, antianginal, warfarin or antihypertensive therapy, peripheral edema, warfarin 
therapy, cardiomegaly and raised jugular venous pressure.(68) 
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The physiological and surgical parameters are divided into four categories with exponentially increasing 
scores of 1,2,4, and 8. If a variable is not available a score of 1 is assigned.(67) In order to calculate the risk 
of suffering from complication, physiological and surgical variables are summed and entered into the 
subsequent equations for mortality and morbidity. (11) For the prediction of a patient’s mortality risk the 
following formula is used:  
ln R/1 -R= -7.04+ (0.13 x physiological score)+ (0.16 x operative severity score)(13) 
For the prediction of the morbidity rate the later equation is used:  
ln R/1- R = - 5.91 + (0-16 x physiological score)+ (0.19 x operative severity score) (13) 
The letter R represents the predictive risk of mortality or morbidity.(13) The POSSUM score ranges 
between 12 and 88 points for the physiologic parameters. Operative parameters are ranging between 6 and 
44 points. Operative and physiologic values are added and represent the POSSUM score.(69) The lower the 
score the less likely is the chance to suffer from major complications.(69)  
1.2.3.1.1 Application 
Several studies have shown that the POSSUM score over predicts mortality especially in a low-risk 
population.(70-72) Therefore the POSSUM score was revised to the Portsmouth POSSUM (P-POSSUM).(72) 
The P-POSSUM uses the same parameters as the POSSUM score. Other than the original POSSUM score 
which uses logistic regression models, the P-POSSUM uses linear models in order to calculate the 
mortality risk.(67) The Portsmouth POSSUM equation was established for predicting mortality: 
ln[R/(1-R)]= - 9.37 + (0.19x physiological score)+ (0.15 x operative severity score)(72) 
The letter R represents the predicted risk for mortality. The alteration of the score predicts mortality more 
accurately in patients who are at low surgical risk.(72) The POSSUM and P-POSSUM was validated in 
different surgical subspecialties such as general, colorectal (17), upper gastrointestinal surgery(73, 74), and 
vascular surgery.(75, 76)  However, it was reported that the POSSUM score has several limitations in 
different surgical subspecialties such as over predicting mortality rates in different subsets of patients.(77, 
78) Therefore specialty specific POSSUM scores have been developed such as the V-POSSUM(79, 80) for 
elective vascular surgery, the CR-POSSUM(77) for colorectal surgery, and the O-POSSUM(81) for upper 
gastrointestinal surgery. The CR-POSSUM reduces the physiologic factors from original 12 values to 6 
values and adjusts for age.(77)The O-POSSUM does not use multiple procedures, total blood loss, and 
peritoneal soiling as operative values. Thus the operative severity score is reduced to three values.(81) 
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Predicting morbidity and mortality with only the physiological parameters has proven to be applicable in 
vascular surgery based on the P-POSSUM equation.(79)  
 
1.2.3.2 Benefits and Limitations 
The POSSUM score is widely acknowledged as a surgical audit tool and surgical risk stratification.(17, 69, 
82) The major advantages of the POSSUM score are that it incorporates intra-operative data, surgical 
parameters, and operative risk. Additionally it predicts thirty-day mortality accurately in an elderly 
population after an age adjustment.(83) The vascular POSSUM score is considered to be a good 
measurement for surgical performance in major vascular surgery.(76) It is argued that the values needed for 
the risk calculation are routinely captured before undergoing surgery and are easily obtained. (71, 72, 84) The 
POSSUM score seems to be applicable in different countries across the world with different accessibility 
to medical resources.(73, 85) The P-POSSUM is reported to predict mortality risk in patients undergoing 
emergency surgery accurately.(82) 
Nevertheless the POSSUM score has several limitations. It is not applicable in children or in day 
patients.(86) It was reported that the P-POSSUM is a better predictor for in-hospital mortality than the 
POSSUM system.(17, 87, 88) However, the P-POSSUM only has a mathematical formula to predict 
mortality. The authors argued that P-POSSUM did not support its use as a reliable tool to predict 
morbidity.(70) Although it is argued that the values for the calculation of the score are easily obtained, 
most variables are not routinely measured and therefore assessing score values is more time consuming 
for the medical staff. (82, 86)The score cannot be easily calculated at the bedside and consists out of a 
complex formula.(11) Additionally the POSSUM score is more likely to over predict mortality especially 
in low risk surgical patients. (70-72)The POSSUM score predicts the overall risk of a patient population. 
Therefore it is not accurate enough to support the clinician’s during the decision making progress for an 
individual patient.(75) For the application of the score, all preoperative data has to be gathered before the 
patient undergoes surgery and the calculation is rather complex. (89) It was reported that 
Electrocardiography (ECG) should only be conducted on elderly patients undergoing a higher risk 
surgery, (60, 90) as patients above 60 years are more likely to present an abnormal ECG.(90)There is no need 
for a preoperative ECG if the patient undergoes a minor surgery.(60, 90) This additional unnecessary 
screening that is needed for the POSSUM risk calculation would add to the already immense workload 
for ward staff. Another major limitation of the POSSUM is that the score is only available after the 
surgery is completed.(67)Adjusting the POSSUM score for different surgical specialties diminishes the 
overall practicability and the ability to compare surgical outcomes across all subspecialties.(91) Copeland 
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also suggested that the POSSUM score should not be used as a risk prediction but only as a surgical audit 
tool.(67) In summary the POSSUM score is not suitable for risk assessment, as gathering data and 
calculating the score is not compatible with the daily routine in surgical care. 
1.3 Surgical Apgar score 
1.3.1 Development of a surgical risk score 
In 1953 Virginia Apgar provided clinicians with a simple ten point scoring system to be used in newborn 
infants in order to assess their postnatal condition and to predict their 28 day survival following birth.(92) 
The Apgar score is determined at minute one, five, and ten after childbirth and gives the clinician 
immediate information on the patient’s condition and on the likelihood of experiencing adverse outcomes 
following birth. Simple in design, the Apgar score is based on the following five factors: the infant’s 
appearance, pulse, grimace, activity, and respiration. Based on the infant’s condition, the young patient 
will be assigned a score from zero to two in each category. At the end of the assessment these points are 
summed together, giving the maximum of 10 points.(93) Ten points represent the highest score an infant 
can reach and corresponds to a condition of excellent health of a newborn.(94) The Apgar score is 
applicable in every hospital setting and since it was first risk stratification system to be applied in 
newborns, it revolutionized obstetrics.(95) Infants at high risk for postnatal complications can thus be 
identified early on, which initiated a cascade of appropriate work up for their poor health and 
interventions to optimize patient outcome.  
Due to a lack of an efficient and simple objective assessment of the patient’s postoperative prognosis, 
Gawande et al. developed a score similar to the Apgar score in 2007 and validated it in general and 
vascular surgery.(8) Previous studies had proven that perioperative tachycardia, low blood pressure and 
considerable blood loss would cause major complications following surgery.(21, 96, 97) By combining these 
three intraoperative values into one score calculated at the end of a surgical case, Gawande derived the 
10-point surgical Apgar score, which is based on routinely measured values: 
• Lowest mean arterial pressure (MAP) 
• Lowest heart rate (HR)  
• Estimated blood loss (EBL) (Table 3) (8) 
Multivariable logistic regression was used to derive the sAs out of 49 preoperative variables, 28 
intraoperative values, and 33 outcomes within a study population that totaled 1,172 patients. The 
aforementioned three independent values including lowest heart rate, mean arterial pressure and estimated 
blood loss were most predictive for postoperative mortality and major complications as defined by the 
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National Surgical Quality Improvement Program’s (NSQIP).(98) These include the following major 
complications: 
• Acute renal failure 
• Bleeding requiring transfusion of ≥ 4 U red cells within 72 hours after operation 
• Cardiac arrest requiring CPR 
• Coma for 24 hours or longer 
• Deep venous thrombosis 
• Septic shock 
• Myocardial Infarction 
• Unplanned intubation 
• Ventilator use for 48 hours or longer 
• Pneumonia 
• Pulmonary embolism 
• Stroke 
• Wound disruption 
• Deep or organ-space surgical site infection 
• Sepsis 
• Systemic inflammatory response syndrome 
• Vascular graft failure(98)  
Gawande’s study was first retrospectively validated in 303 patients undergoing vascular and general 
surgery at the Brigham and Women’s Hospital in Boston, Massachusetts. Beta-coefficients were used to 
allocate appropriate weight to each of the chosen variables on a suitable 10-point scale. The intervals 
between the points were chosen such that a one-point increase in a patient’s sAs would significantly raise 
the occurrence of postoperative complications (relative risk of 16.1 among patients with a surgical Apgar 
score below 4 points) and additionally showed clinical significance. Table 3 delineates the construction of 
the surgical Apgar score by component. A patient with a lowest heart rate of 54 beats/minute (4 points), 
lowest mean arterial blood pressure of 80 mmHg (3 points) and estimated blood loss of 50 ml (3 points) 
would receive the maximum sAs of ten. In contrast, a lowest intraoperative heart rate of 80 beats/minute 
(1 point), lowest mean arterial blood pressure of 50 mmHg (1 point) and an estimated blood loss of 700 
ml (1 point) would equal a surgical Apgar score of three. The second patient with a sAs of three would 
have an increased risk (relative risk 15.4 [CI 7.2-33.1])	 of suffering from postoperative complications 
compared to the first patient with a sAs of ten. As this example illustrates, the risk for mortality and 
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morbidity increases significantly with decreasing sAs.(8)  
 
 
 
Table 3. Ten-point Surgical Apgar Score 
   0 Points 1 Point  2 Points 3 Points 4 Points 
Estimated blood              > 1000             601-1,000 101-600   ≤ 100       -- 
loss (mL)
 
Lowest mean arterial    < 40  40-54  55-69     ≥ 70       -- 
pressure (mmHg) 
 
Lowest mean heart rate     >85  76-85  66-75     56-65    ≤ 55* 
(beats/minute) 
Table 3. The surgical Apgar score = sum of the points for each category in the course of the procedure 
*Occurrence of pathologic bradyarrhythmia, including sinus arrest, atrioventricular block or dissociation, junctional or 
ventricular escape rhythms, and asystole also receive 0 points for lowest heart rate. 
 
Concurrently, Gawande et al. conducted a further prospective study with 869 patients undergoing 
vascular and general surgery at the same institution to validate the sAs and to evaluate the accuracy of the 
sAs in predicting postoperative morbidity and mortality.  This study proved the surgical Apgar score to be 
adept in predicting the patient’s risk for major complications and death within 30 day following 
surgery.(8)In 2009 the predictive ability of the surgical Apgar score was revalidated in 4,119 patients 
undergoing vascular and general surgery at the Massachusetts General Hospital in Boston. In this study 
electronic data records were used instead of handwritten intraoperative charts, which the score was 
initially derived from.(19)  
1.3.2 Utility of the surgical Apgar score 
Most risk scoring systems were developed for the use in an intensive care unit and there is still a lack of a 
rating which is applicable during surgical procedures.(99) Multiple studies have reported that intra-
operative blood loss(13, 21), tachycardia(96, 100), bradycardia (100, 101), hypertension, and hypotension(102-104) are 
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independently associated with patient’s outcome. By combining these three predictive values has proven 
to predict a patient’s postoperative risk of suffering from major complication.(8) Hypotension, tachycardia 
and extensive blood loss are very likely to be treated individually by clinicians. However each variation in 
vitals has an impact on the patient, which is captured by the surgical Apgar score. In several studies the 
sAs has proven to predict the morbidity and mortality rate adequately. (8, 18, 105-108) The 10-point scoring 
system is easily understandable and might help communication between the surgical team, the 
postoperative care team, the medical staff on the wards and the patient. A low sAs could support a 
clinician’s decision to transfer the patient to an intensive care unit, where close monitoring and one to one 
nursing is possible. In recent studies a low surgical Apgar score has proven to be predictive for intensive 
care unit (ICU) admission(109, 110) and increased length of ICU stay in general surgery.(110) Furthermore 
Glass et al. described that the sAs is also associated with late transfer to the intensive care unit.(110) 
Patients with higher scores are more likely to be transferred to the ward where close monitoring is not 
necessary. (111) The surgical Apgar score immediately identifies patients who are at a higher risk of having 
major complications. Patients who were undergoing minor vascular or general surgery at the 
Massachusetts General Hospital and had a surgical Apgar score of 4 or less were 22.8 times more likely 
to develop major complications and 81.4 times more likely to die within 30 days after a surgical 
procedure.(19)Patients who underwent major or prolonged general or vascular surgical procedures at the 
same institution with a score of 4 or less were 6.5 times more likely to experience major complications 
and 112.0 times more likely to die within 30 days.(19) The surgical Apgar score can only predict the 
patient’s risk for major complications and risk but it cannot measure the surgical team’s intraoperative 
performance or can compare different clinicians and institutions, as the score does not take surgical 
complexity and patient’s relevant risk factors into account. (18) Patients with greater blood loss have lower 
sAs and thus have an increased risk for major complications. Surgeons with greater EBL at the end of a 
surgical case would be therefore more likely to better predict patient’s outcome. Consequently the score 
does not operate as an audit tool. (18) 
However the surgical Apgar score is applicable in all different types of anesthesia with the exception of 
local anesthesia as no electronic records are available.(8) The surgical Apgar score could also be used as a 
tool to aid researchers worldwide to improve surgical procedures in their individual hospital setting and 
ensure patient’s safety.(112, 113)  
1.3.3 Validation of the surgical Apgar score  
Since the development of the surgical Apgar score in patients undergoing vascular and general surgery, 
the risk assessment was validated in different surgical procedures and various surgical specialties, such as 
urological, colorectal, gynecological, pancreatic surgery and spine surgery. (105-107, 111, 114, 115) The score has 
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also demonstrated usefulness in renal mass excision,(116) and  predicting ICU admission after general 
surgery.(109)  The sAs was validated in a wide range of international clinics and it was reported that the 
score is applicable in almost every hospital setting. Due to its simplicity in gathering the data for the 
score, resource poor hospitals can still apply the sAs. (112) Other risk scores, which rely on multiple 
variables and laboratory values, might not be calculated in different clinics throughout the world due to 
the expense factor.  In some countries the vitals are being monitored manually in others electronically 
which leads to variability in obtaining the risk score. (108, 112) However, the sAs can also be derived from 
hand written anesthesia charts, as it was first validated form manually captured records.(8) The surgical 
Apgar score was validated in neurosurgical study population at the University of Michigan hospitals. In 
this study, the score was predictive for major complications, prolonged hospitalization, and intensive care 
unit stay.(117) Ohlsson et al. validated the association between perioperative complications and the surgical 
Apgar score, intensive care unit and hospital length in a Swedish setting.  Lower sAs were strongly 
correlated with longer hospitalization and length of stay at an intensive care unit.(108) Melis et al. 
demonstrated the predictive ability of the surgical Apgar score in a veteran population undergoing general 
surgery.(118) In a recent study conducted in Japan, the surgical Apgar score was validated after 
gastrectomy for gastric cancer. Miki et al. modified the surgical Apgar score by using the quartile values 
of EBL as their median sAs was lower than in general surgery. This manuscript demonstrated that a 
modified sAs is an independent predictor for major complication in this particular study population.(119) 
Validating the sAs in hip and knee arthroplasty it was demonstrated that the score is not a reliable risk 
measurement. Only 6.1% of the patients with major complications had a score of 4 or less. 75.8% of 
patients with major complications had a score of 7 or higher.(113) Recently, it was reported that the 
surgical Apgar score is applicable in all major surgical subspecialties in predicting postoperative 
mortality.(120) However, the predictive ability of the sAs varies among different surgical subspecialties. 
The correlation between sAs and burn patients is very weak, whereas the relationship between the 
predictive ability of sAs in gynecology is very high. Different patient spectrum with various 
comorbidities might be accountable for the variation within the subspecialties.(115, 120) Nevertheless the 
surgical Apgar score still remains a valuable risk score in several validated subspecialties. (120)  
1.3.4 Benefits of the surgical Apgar score 
The surgical Apgar score is an objective measurement of the patient’s condition and will provide the 
clinician with more information about the patient’s postoperative well being without requesting additional 
diagnostic testing. As the values for the calculation of the score are already routinely captured,	 the sAs 
could be incorporated into routine clinical practice with minimum resource implications. Furthermore, no 
particular schooling or equipment is required to assess the score.(118) The variables used to calculate the 
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surgical Apgar score are influenced by many different factors, such as anesthesia care and medication, the 
patient’s prior condition, age, operative complexity, and the surgical team. (101, 105, 118, 121, 122) The 
estimation of the blood loss adds a subjective component to the score that incorporates the clinicians 
experience and the competent evaluation of the situation. By using intraoperative vital measurements, the 
score takes the magnitude of the operation performed, patient’s intraoperative responsiveness to the 
procedure and postoperative condition into account. The calculation of the sAs at the end of a surgical 
case helps clinicians to identify patients who are at a higher risk of having major complications and 
immediate action, such as close monitoring on a step down unit or transfer to the intensive care unit, can 
be taken to prevent any incidents. (18) Patient’s safety and better hospital outcomes might improve by 
applying the sAs as a routine measurement. 
1.3.5 Limitations of the surgical Apgar score 
There are several limitations to the surgical Apgar score. One major criticism of the score is the 
estimation of the blood loss. The original authors argue that the ranges set for the estimation of blood loss 
should provide an accurate estimate based on published studies. (8, 123, 124)  
Some studies noted that the sAs might not comprehensively predict outcomes by itself: The surgical 
Apgar score did not support its use as a reliable tool to predict adverse events in hip and knee 
arthroplasty.(113) However, the score provided useful information to perioperative risk in this study 
population.(113) Recent results of Lau et al. indicated that sAs is not able to predict major complications 
following spinal metastasis surgery. Though this study only included a small study population of ninety-
seven patients and therefore needs to be revalidated in a larger patient cohort. (125)A study, which was 
conducted in a district general Hospital in the United Kingdom, has shown that the surgical Apgar score 
has a low predictive ability for major complications and mortality in orthopedic cases such as elective 
major joint replacements and emergency femur fracture cases. In the same study it is supposed that the 
sAs does not improve individual postoperative care. (126) Urrutia et al. validated the sAs in general 
orthopedic surgery and the score failed to demonstrate usefulness in this study population. The score was 
only predictive in a subgroup of patients undergoing spine surgery for major complications.(127) Another 
frailty of the surgical Apgar score is that the anesthetic management and medication influence the 
variables used to calculate the score. (112) Hypotensive episodes may occur during induction due to various 
reasons and would subsequently lead to a lower sAs.(128, 129) Furthermore bradycardic episodes during the 
surgery cause a higher surgical Apgar score. However many studies have shown that intra-operative 
hypotension and tachycardia contribute significantly to a negative outcome, regardless of their cause.(96, 97, 
121, 130, 131) Another of the sAs’s limitations is that vitals must be captured automatically or manually at 
least every 5 minutes in order to obtain an appropriate score. (112)So far the sAs is only applicable in an 
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adult population.(19) Nevertheless, the surgical Apgar score remains a solid predictor for postoperative 
negative outcome.(18, 19) 
1.3.6 Continuous Evaluation of the Surgical Apgar Score 
Measurement of risk for postoperative complications before, during, and after surgery is important in 
guiding medical decision making. Having a better understanding of when a patient’s risk profile changes 
during a surgical procedure is an important goal which might guide more timely interventions, triage 
decisions, and enhance communication among the perioperative team. In spite of rapid technological 
advances, the state of the art with respect to perioperative risk measurement and appropriate real-time 
notification systems about perioperative risk and dynamic changes in operative risk is still quite 
limited.(132)  
The surgical Apgar score was developed and validated using data available and applied at the end of the 
case. However monitoring the sAs trends throughout a case is possible and may provide additional 
information. Real-time assessment of the surgical Apgar score and notification systems apprising 
clinicians of rapid changes in a patient’s surgical Apgar score may represent an objective tool to aid 
clinicians in their decision making process, allowing them to rely on objective data rather than on 
intuition and clinical experience in creating summative evaluations of patient condition. Additionally, the 
risk score may support the clinician’s request for additional diagnostic testing, invasive patient 
monitoring, ordering a transfer to the intensive care unit and intensifying medical care. We hypothesize 
that continuous surgical Apgar score monitoring may be used intraoperatively to identify patients at high 
risk of postoperative complications. 
1.4 Comparison of surgical risk scoring tools 
Table 4. displays the different risk scores with components and main limitations which are discussed in 
this dissertation.  
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Table 4. Comparison of surgical risk scores 
Risk score                           components           main limitations 
       
ASA classification general medical history  
general examination 
subjective assessment 
inconsistent rating  
   
 
      
Revised Cardiac risk index  high-risk type of surgery Only prediction of major cardiac 
complications  
 History of ischemic heart disease No mortality prediction 
 History of congestive heart 
failure 
 
 History of cerebrovascular 
disease 
 
 Preoperative treatment with 
insulin 
 
 Preoperative serum creatinine 
>2.0 mg/dL 
 
            
      
POSSUM physiological parameters Only applicable in hospitalized 
patients   
 Age Many variables 
 Cardiac signs Complex calculation 
 Respiratory history  
 Blood pressure  
 Pulse rate  
 Glasgow Coma Score  
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 Hemoglobin level  
 White cell count  
 Urea concentration  
 Sodium  
 Potassium  
 Electrocardiography  
 
 Operative parameters  
 Operative severity  
 Multiple procedures  
 Total blood loss   
 Peritoneal soiling  
 Presence of malignancy  
 Mode of surgery  
 
Surgical Apgar score Lowest heart rate Estimation of blood loss 
imprecise 
 Lowest mean arterial pressure Variation in predictive ability 
 Estimated blood loss Variables influenced by 
cofactors 
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2 Specific Aims 
The purpose of this study is to determine whether a continuous real-time assessment of the surgical Apgar 
score across the entire duration of a surgical case can provide additional information about the patient’s 
postoperative condition when compared to a single sAs value determined at the very end of the procedure. 
By extending the utility of the sAs and transitioning from a single end-of-case value to a continuous trend 
that can be monitored and used throughout the perioperative process, we expect that more timely 
interventions in response to drastic fluctuations in surgical Apgar scores can reduce perioperative 
morbidity and mortality. 
2.1 Revalidation of the surgical Apgar score in our study cohort  
At first the correlation between the end-of-case surgical Apgar score and major postoperative 
complications will be evaluated to re-validate the sAs in our study cohort and prove its applicability for 
our model. In previous studies the surgical Apgar score has demonstrated predictive ability in terms of 
postoperative patient morbidity and mortality, where patients with lower scores had a significantly 
increased occurrence of major postoperative complications within thirty days of surgery. To re-validate 
the end-of-case sAs in our study cohort, the predictive ability of the sAs for postoperative adverse events 
will be examined.  
2.2 Evaluation of surgical Apgar score trends in twenty different surgical subspecialties 
We will investigate whether continuous monitoring of the sAs throughout the perioperative process and 
evaluation of sAs trends may allow for more optimal patient risk stratification. We will investigate the 
association between sAs trends and major perioperative complications. Subsequently these sAs trends 
will be analyzed for each surgical subspecialty included in this study. Trends in sAs may vary based on 
patient characteristics, surgical subspecialty investigated and duration of the procedure. The trend 
calculation will be based on mean sAs, coefficient of variation, and slope of sAs throughout the 
procedure. Lastly we will examine whether these trend characteristics are associated with postoperative 
morbidity or mortality.  
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2.3 Real-time assessment of surgical Apgar score in general, vascular, and general 
oncology surgery 
To establish continuous assessment of the surgical Apgar scores, the sAs will be calculated at serial points 
in time throughout a case whenever new values required for the calculation are recorded in the patient’s 
electronic anesthesia chart. Continuous sAs calculation will be conducted in general, vascular, and 
general oncology surgery. Hypothetical real-time assessment of the score will be established.  
2.4 Comparison of the predictive ability between continuous assessment of surgical 
Apgar score and the American Society of Anesthesiologists physical status 
classification system 
The ASA classification is widely used throughout the world as a risk stratification model for surgical 
patients. We will compare the predictive ability of the ASA classification system to that of continuous 
sAs monitoring in the form of sAs trend analysis. Additionally, the two scores will be combined into a 
single model and assessed for their predictive ability. For the combined model, analysis will be based on 
surgical Apgar scores calculated continuously throughout the surgery.  
2.5 Establishing a model for a threshold probability 
The surgical Apgar score serves as a clinical tool that helps predict the risk or probability for morbidity 
and mortality following surgery. We will design a model that raises a hypothetical alert when a patient 
that underwent general, vascular, or oncology surgery, exceeds a predetermined probability of 
postoperative complications based on his/her sAs trend. Since patients crossing this chosen threshold 
might exhibit higher admission rates to the intensive care unit, might require longer postoperative 
hospitalization, and might be more likely to suffer from postoperative morbidity and mortality, they might 
benefit from earlier and more aggressive interventions in the operating room.  
2.6 Applying thresholds in hypothetical patient populations 
All surgical procedures will be electronically re-analyzed to re-validate our model in a hypothetical 
patient population based on our original study cohort. Hypothetical alerts will be raised if a patient 
crosses a predetermined threshold probability for postoperative complications. As trends are able to 
capture acute changes in a patient’s status, they may alert clinicians earlier about impending adverse 
events that can lead to postoperative morbidity and mortality. We will investigate at which point in the 
surgical procedure the first alert was raised. Lastly we will determine the predictive ability of the alert 
model. 
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3 Methods  
3.1 Overview 
We conducted a retrospective evaluation of patients who underwent non-cardiac surgery under general 
anesthesia performed at the Vanderbilt University Medical Center between January 1, 2009 and 
December 31, 2011. We divided the study in two parts: 
In the first part of the study we investigated surgical Apgar score trends in twenty surgical subspecialties. 
In the second part of the study we conducted a retrospective evaluation of patients who had general, 
vascular, or general oncology surgery.  
We evaluated the continuous monitoring of the surgical Apgar score by developing a model of real-time 
assessment of the risk score during surgery performed in these three subspecialties. General surgery and 
vascular surgery were chosen for our study since the surgical Apgar score had originally been validated in 
these subspecialties.(8) General oncology was chosen due to the large sample size of the patient cohort 
giving a solid statistical basis.  These three surgical subspecialties should serve as a model to verify or 
nullify the validity of the hypothesis stated in the introduction.  
In addition we established alerting models based on the patient cohort on the second part of the study. 
Surgical subspecialties were defined by the primary service of the attending surgeon or the scrub nurse. If 
no service is assigned, the surgeon’s department will be automatically pulled into the “Primary Service” 
field in the patient’s chart. Intraoperative data were extracted from the Vanderbilt Medical center’s 
perioperative data warehouse. The Vanderbilt University Human Research Protection Program, Nashville, 
TN, approved the study.  
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3.2 Patient population 
Electronic records and Perioperative Information Management System databases were used to identify 
relevant patient characteristics, as defined below in data collection. The following measures were taken to 
refine our study population. Patients undergoing surgery over the age of 18 were eligible for inclusion.  
Characteristics of excluded patients are listed in Table 5. 
Table 5. Excluded Patient Characteristic 
Patient characteristic               Count n = 209,949 
Non-operative cases         97,664 
Age < 18          39,581  
Single EBL recording >100 ml        39,048 
Incomplete medical record        13,137  
Other than general anesthesia        12,752 
Cardiac patients            5,312 
Community surgical patients          2,371  
Age >100                 41 
Organ donors                 21 
Test patients                 10 
Date of Death>Surgery Start Date              12 
All                     209,949 
Table 5. displays the number of patients excluded from the study for the reasons cited. 
 
Since patients over the age of 100 years are more likely to die of causes other than the direct aftereffects 
of the surgery, they were excluded from the study. All organ donors, classified as ASA 6, were excluded. 
Patients cared for in off-campus surgical centers and non-operative cases (i.e. bronchoscopy, dental 
procedures, procedures in the intensive care unit, gastrointestinal, radiological and electrophysiology 
cases) were excluded, as were patients with incomplete patient data. We excluded patients with only a 
single documented blood loss recording at the end of the case and if the blood loss recording was greater 
than 100 ml. This allowed us to avoid sudden artificial changes of sAs trends at the end of a case in which 
patients’ blood loss was not documented as it occurred throughout the procedure. Furthermore, all cardiac 
patients were excluded as most patients underwent a cardiopulmonary bypass procedure in which patients 
do not have a heart rate or a mean arterial pressure. In the absence of these recordings the sAs cannot be 
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accurately calculated thereby mandating exclusion of these patients from the study. During investigation 
twelve patients were noted to have died before undergoing surgery, although they were, in fact, operated 
on. After further inquiry, the date of death had been incorrectly captured in the electronic database and 
consequently these patients were excluded. Lastly, all cancelled and test cases were excluded. Test 
patients are entered into the database for various learning purposes. 
 
3.3 Data collection 
Electronic records and Vanderbilt Perioperative Information Management System databases (VPIMS) 
were used to compute the surgical Apgar score and to identify relevant patient characteristics.  All 
perioperative electronic data is stored in a data warehouse using Microsoft Structured Query Language 
(SQL) server technology (Microsoft Corporation, Redmond, WA). All pre- and postoperative data were 
excluded. The following variables were then extracted from the Vanderbilt Perioperative Data Warehouse 
(PDW):  
• Patient demographics 
• Medical record number 
• Date of birth 
• Gender 
• Race 
• Surgery date 
• Surgery start 
• Medical encounter number 
• Hospital admission date 
• Hospital discharge date 
• Anesthesia patient number 
• Anesthesia case number 
• Indication (emergency or elective surgical procedure) 
• Age on day of surgery 
• Type of primary surgical procedure 
• Surgery date and starting time 
• Length of the surgical procedure 
• American Society of Anesthesiologists Physical Status Classification 
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• Time of vital recording  
• Heart rate 
• Mean arterial blood pressure 
• Estimated blood loss 
Medical record number, surgery start date and time, and time of vital sign recordings make a case unique. 
All values for heart rate (HR), mean arterial blood pressure (MAP), and estimated blood loss (EBL) were 
extracted from the Enterprise Data Warehouse database, as time stamped data. Heart rate is recorded 
every 30 seconds, either electronically through the Plethysmogram, the electrocardiogram or manually 
when clinicians enter the heart rate into the patient’s chart. Mean arterial blood pressure is captured every 
three minutes.  Blood pressure was either measured noninvasively or invasively via an arterial line and 
sometimes required manual adjustment by clinicians. When both noninvasive and invasive blood pressure 
recordings were documented, we used the invasively monitored blood pressures since they are more 
accurate. Inaccuracies in the measurement of the heart rate and mean arterial pressure were noted when 
the catheter was flushed or the arm repositioned. To avoid artifacts, heart rate values outside of the range 
of 15 mmHg to 200 mmHg were discarded. MAP ranges were defined as 25-180 mmHg.  
Our primary endpoint was death within 30 days of surgery or the occurrence of the following major 
postoperative complications within 30 days of the procedure:  
• Acute renal failure 
• Bleeding requiring transfusion of ≥ 4 units red cells within 72 hours after operation 
• Cardiac arrest requiring CPR 
• Coma for 24 hours or longer 
• Deep venous thrombosis 
• Septic shock 
• Myocardial Infarction 
• Unplanned intubation 
• Ventilator use for 48 hours or longer 
• Pneumonia 
• Pulmonary embolism 
• Stroke 
• Wound disruption 
• Deep or organ-space surgical site infection 
• Sepsis 
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• Systemic inflammatory response syndrome 
• Vascular graft failure(98)  
The selection and definition of major complications was based on the National Surgical Quality 
Improvement Program (NSQIP) registry, which collects peri- and postoperative data from various 
institutions for a comparative analysis of complication rates and surgical outcomes.(133) (134) 
ICD 9 codes, which are stored in the Perioperative Data Warehouse in association with each medical 
record, were used to identify peri- and postoperative complications. Data for wound disruption, ventilator 
use for 48 hours or longer, bleeding requiring ≥ 4 units red cell transfusion within 72 hours after 
operation, and unplanned intubation were extracted from the Vanderbilt Enterprise Data Warehouse 
(EDW; Oracle Corporation, Redwood Shores, CA) based on International Classification of Diseases ninth 
revision (ICD-9 codes) in the patient’s chart. The medical record number was matched to ICD-9 codes 
corresponding to the postoperative complications defined above in order to identify study subjects who 
experienced adverse events prior to discharge or were readmitted to Vanderbilt University Hospital within 
30 days. Patients’ social security numbers were compared to the Social Security Death Index provided by 
the U.S. government in order to identify the date of death.  
3.4 Study procedure 
The surgical Apgar score was determined based on the lowest intraoperative heart rate, the lowest mean 
arterial blood pressure and estimated blood loss, following the protocol proposed by Gawande et al. in 
2007.(8) Vanderbilt Perioperative Data Warehouse records were used to retrieve information necessary to 
compute the surgical Apgar score during the maintenance phase of each surgical procedure.  Maintenance 
phase is defined as the time interval between “Anesthesia Ready Time” and “Dressing on Time,” both of 
which are manually entered by the operating room nurses.  
3.5 Validation of surgical Apgar score in all surgical services 
The first part of the study compromised all surgical patients who met our inclusion criteria. The end-of-
case surgical Apgar score was revalidated in our study cohort. The frequency of major complications 
within 30 days of surgery was computed and the distribution of the ASA classification was recorded. We 
calculated the odds of experiencing a major complication for every one-unit increase in surgical Apgar 
score by using binary logistic regression. 
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3.5.1 Real-time assessment of surgical Apgar score 
The Surgical Apgar score was calculated each time new information (i.e. vital signs or electronic 
documentation of blood loss) was documented in the patient’s electronic record (typically every 30-60 
seconds). Specifically, as time advanced, we used all data available up to each time-point in which new 
data appeared to calculate the surgical Apgar score utilizing the lowest intraoperative HR and MAP. 
Whenever new data were subsequently recorded, the lowest intraoperative HR and MAP values were 
used for the calculation of the surgical Apgar score. As in Regenbogen et al. heart rate values outside the 
range of 20 to 200 beats per minute and mean arterial pressures outside of the range of 25 to 180 mmHg 
were interpreted as artifact and were discarded.(19) Points assigned for estimated blood loss were renewed 
each time EBL was updated and then were added to the score determined for the patient’s heart rate and 
mean arterial pressure to compute the overall surgical Apgar score. On average, blood loss was recorded 
in 15-minute intervals during standard surgical procedures without extensive blood loss. Data on 
resuscitation (with fluids and blood products) was not included in the analysis. 
Estimated blood loss is a subjective measure, manually recorded into the patient record. The amount is 
determined by adding the estimated amount of blood within the collection container to that absorbed 
within used collecting gauzes. Finally the surgeon is consulted to attest the estimated amount of blood 
loss. The sAs was computed every minute new data were available by summing the points for lowest 
recorded MAP, heart rate value, and EBL at that point in time. The last lowest value for heart rate and 
mean arterial pressure were used throughout a case. Points given for the estimated blood loss are added to 
the points given for HR and MAP. (Table 3)  
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Figure 1. Calculation of surgical Apgar score 
 
Figure 1 displays example intraoperative heart rates, blood pressure, and oxygen saturation at various time points within a 
surgical procedure. The arrows indicated what heart rate value was used to calculate the surgical Apgar score at certain time 
points. 
3.6 Statistical Analysis 
All statistical analyses were computed using SAS 9.3 statistical software package (SAS Institute, Cary, 
NC) and R version 3.0.3 (Vienna, Austria).  Surgical Apgar scores were calculated for each patient as 
previously described(8) and examined for their association with the proposed postoperative complications.  
Univariate analysis was performed on age, gender, ASA class, surgical Apgar score, lowest heart rate, 
estimated blood loss, lowest mean arterial pressure, minutes spent in the operating room, complications, 
death and primary service. Given that the categorical nature of the independent variable was continuous 
and categorical, we chose to use logistic regression. In the second part of the study we categorized 
patients by their surgical Apgar score value 0 to 4, 5 to 6, 7 to 8, and 9 to 10. Scores ranging from 0 to 4 
were merged due to small sample sizes in the lowest categories. 
3.6.1 Bivariate statistical analysis 
Pairwise analyses were performed to evaluate the association between demographic and operative patient 
characteristics and major postoperative complications within 30 days of surgery. P-values less than 0.05 
were considered statistically significant. Chi2 test was used to compare categorical data whereas one-sided 
t-test was used for continuous data. Chi2 test was used to assess the association between each level of the 
surgical Apgar score and major postoperative complications within 30 days of surgery. As previously 
described(18, 109, 112) we chose patients with a surgical Apgar score of 7-8 as our comparison group.  
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3.6.2 Univariate logistic regression models 
The study population was divided in two different cohorts. The first cohort consisted of patients who did 
not suffer from major complications or death while the second cohort was comprised of patients with 
complications or death within 30 days of surgery. Simple logistic regression was used to assess the 
association of end-of-case surgical Apgar score with investigated outcomes. P-values less than 0.05 were 
considered statistically significant. In order to determine if patients with low end-of-case surgical Apgar 
scores exhibited higher rates of major postoperative complications and mortality, univariate logistic 
regression was employed. Univariate logistic regression models were applied to determine the predictive 
ability of the sAs and the ASA classification.  
3.6.3 Receiver operator characteristic curve 
The Receiver operating curve (ROC curve) is an assessment of the predictive value of a test and is 
graphically represented by plotting sensitivity versus 1-specificity.(135) Sensitivity represents the 
proportion of true positives (i.e. patients who did indeed suffer from major complications) whereas the 
specificity is a measure of true negatives (i.e. patients who truly did not suffer from major 
complications).(136) The closer the Area under the curve (AUC) is to the value of one, the better is the 
discrimination.(136)An AUC of 0.5 cannot distinguish between patients with and patients without major 
complications and therefore marks a test as useless.(137) The AUC represents the probability of suffering 
from major complications for patients with lower surgical Apgar scores.(138) ROC curves were plotted and 
the area under the curve was calculated for sAs and the ASA classification.  
 
3.6.4 Mulitvariate Logistic Regression 
Multivariate logistic regression models predict outcome of a categorical variable that depends on multiple 
covariates or independent variables. We established logistic regression models to analyze the trends of 
surgical Apgar score throughout a surgical procedure in general, vascular and general oncology surgery. 
3.6.4.1 Multivariate Logistic Regression for surgical Apgar score 
We designed a multivariate logistic regression model to assess the relationship between low, intermediate, 
and high mean sAs, variation (high and low coefficient of variation) of sAs, and change (slope positive 
and negative) of sAs throughout the procedure and the likelihood of having a major complication. 
A positive coefficient variation indicates that a high variability in surgical Apgar scores over time is 
significantly associated with mortality and morbidity. The more stable the sAs was during a surgery, the 
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less likely was the patient to suffer from major complications. Patients with a mean sAs of four to seven 
were used as a reference. This statistical analysis was applied for all surgical patients included in this 
study. 
3.6.4.2 Model for surgical Apgar score real-time assessment  
Eight different models were constructed for general, vascular, and general oncology surgery, as described 
in Table 6. These models are denoted as follows: the ‘ASA,’ ‘sAs,’ ‘sAs and ASA,’ ‘HR,’ ‘HR and 
ASA,’ ‘MAP,’ ‘MAP and ASA,’ ‘HR, MAP, and ASA.’ The ‘ASA’ model uses the ASA classification 
assessed prior to the procedure, as well as the patient’s age, race, and gender to estimate the probability of 
major complications. The ‘sAs’ model uses continuously monitored surgical Apgar score and derived 
factors, age, gender, and race to predict adverse events. The ‘sAs and ASA’ model combines these two 
models. The ‘HR’ and ‘MAP’ models are similar to the ‘sAs’ model, substituting heart rate or mean 
arterial pressure for surgical Apgar score. These two models are combined with the ‘ASA’ model and 
displayed as the ‘HR and ASA,’ ‘MAP and ASA,’ and ‘HR, MAP, and ASA’ models. Interactions 
between the current value of continuously measured factors and each of the two associated derivates were 
also considered. 
36 
 
Table 6. Description of Prediction Models 
Model   Description 
‘ASA’   ASA class assessed prior to surgery adjusted for age, race, and gender 
‘sAs’ Continuously monitored surgical Apgar score adjusted for age, race, and           
gender 
‘sAs and ASA’ Combination of continuously monitored surgical Apgar score and ASA class 
assed prior to surgery adjusted for age, race, and gender 
‘HR’  Continuously monitored heart rate, largest drop in heart rate from the baseline 
heart rate to the most recent recording, and the heart rate insult 
‘HR and ASA’ Combination of continuously monitored heart rate, largest drop in heart rate from 
the baseline heart rate to the most recent recording, and the heart rate insult and 
ASA class assessed prior to surgery  
‘MAP’  Continuously measured mean arterial pressure assessed during surgery, the 
largest drop in mean arterial pressure from baseline to the most recent recording, 
and the mean arterial pressure insult 
‘MAP and ASA’  Combination of continuously measured mean arterial pressure assessed during 
surgery, the largest drop in mean arterial pressure from baseline to the most 
recent recording, and the mean arterial pressure insult and ASA class assessed 
prior to surgery  
‘HR, MAP and ASA’ Combination of continuously monitored heart rate, largest drop in heart rate from 
the baseline heart rate to the most recent recording, and the heart rate insult, 
continuously measured mean arterial pressure assessed during surgery, the largest 
drop in mean arterial pressure from baseline to the most recent recording, and the 
mean arterial pressure insult, and ASA class assessed prior to surgery 
Table 6 provides a detailed description of the eight risk models examined for their predictive ability in regard to postoperative 
complications. 
 
37 
 
3.6.4.3 Analysis of continuously monitored surgical Apgar score 
Logistic regression models were used to intraoperatively update the risk of postoperative mortality or 
major complication, conditional on preoperative (i.e. baseline) and continuously monitored clinical 
factors, including heart rate, mean arterial pressure, blood loss, surgical Apgar score, and derived factors. 
At each intraoperative time-point, all continuously monitored factors were additionally summarized using 
two derived factors: the largest drop from baseline to the most current measurement, and a measure that 
we denote “insult.” Insult represents the cumulative drop in a continuously monitored factor from 
baseline to the current measurement (Figure 2). That is, when the current value of a continuously 
monitored factor is greater than or equal to the baseline value, the contribution to insult is zero. When the 
value is below baseline, the contribution to insult is positive. For example, if the heart rate falls 10 beats 
per minute (bpm) below the baseline value and remains there for 10 minutes, then the corresponding 
insult is 10 bpm × 10 minutes. An identical insult would occur if the decline in heart rate were 20 bpm 
and lasted for 5 minutes. The magnitude of insult may grow over the course of a procedure, but not 
shrink. 
Logistic regression was implemented by assigning each patient’s outcome (one per patient) to every 
corresponding intraoperative record (multiple per patient).  
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Figure 2. Hypothetical Alert Model 
 
Figure 2. Illustration of an example heart rate (bpm) over procedure time (min) and the positive, cumulative contribution every 
drop in heart rate below the baseline value makes to HR insult. Shaded areas demark heart rate values below baseline during the 
procedure. The second graph illustrates how drops in heart rate cumulatively contribute to HR insult and thereby account for the 
depicted rise in HR insult over time. 
 
3.6.5 Development of an Alert Model 
 
Once the prediction models were fitted, we proposed a protocol for raising a hypothetical alert during a 
surgical procedure if a predetermined threshold probability for postoperative complications was reached.  
Each risk model was used to evaluate a protocol for raising notifications intraoperatively. Based on the 
risk estimate at each intraoperative record, and for a sequence of threshold probabilities, we noted the 
procedure time at which the first notification would have been raised. Procedures where no notification 
was given were also noted. Box and whisker plots were used to display the times of first alert at various 
threshold probabilities. Since the ‘ASA’ model utilizes only preoperative information, an alert may only 
arise at the beginning of the surgical case. In contrast, the ‘sAs and ASA’ model may activate an alert at 
any time during the procedure. In particular, the current procedure duration, current surgical Apgar score 
and three derivatives of the surgical Apgar score history (baseline surgical Apgar score, maximum drop in 
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score from baseline, and insult) were used for the prediction. Interactions between the current surgical 
Apgar score and each of the three derivatives were also considered.  
The discriminative value of notification protocols was assessed for each model and surgical service by 
constructing receiver operating characteristic (ROC) curves and computing the area under the ROC curve 
(AUROC). AUROC values were compared among models in a pair wise manner by constructing a 95% 
confidence interval for the ratio (expressed as a percentage) of two AUROC values. The AUROC 
estimate in the general surgery cohort was internally validated using a bootstrap validation technique.(139) 
We used this technique to test the “goodness-of prediction” of our model, the study population was 
replaced using 5,000 bootstrap replicates at the patient level, and the model was validated in this “new” 
cohort. In addition to these summaries of model discriminative value, calibration curves associated with 
the ‘sAs and ASA’ model are presented for each surgery service at procedure times 0, 60, and 120 
minutes. 
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4 Results  
4.1 First part: Surgical Apgar score in all surgical subspecialties 
4.1.1 Patient Characteristics  
Of 46,245 patients who fulfilled inclusion criteria, we obtained complete electronic intra-operative 
documentation on 33,108 patients (71.59%); this group comprised our final study cohort for the first part 
of the study. Demographic and intra-operative characteristics of the study population are displayed in 
Table 7. Patients with major complications are compared to patients without major complications. The 
overall incidence of major complications 30 days after undergoing a surgical procedure was 14.37%, 
corresponding to a total of 4,757 patients. Major complications included 342 (1.03%) deaths. Mean age of 
the study population was 51.0 years with patients suffering from major complications being on average 
one year older than patients without complications (p<0.001). Women represented 46.16% of the study 
population but made up 38.32% of patients with major complications in comparison to a 61.61% 
complication rate in the male population. Bivariate analysis showed that women were less likely to 
experience major complications (p<0.001). Patients with a higher American Society of Anesthesiologists’ 
Physical Status Classification were associated with a significant increase of major complications 
(p<0.001). The lowest heart rate (65.84 versus 57.40) was significantly higher (p< 0.001) and the lowest 
mean arterial pressure (51.00 versus 52.27) was significantly lower among patients suffering from major 
complications (p<0.001). Patients with blood loss exceeding 950 ml were more likely to suffer from 
major complications (p <0.001). Longer operation duration (233.41 minutes versus 201.75 minutes) was 
significantly associated with major postoperative complications (p<0.001).  
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Decreasing sAs were significantly associated with an increase of major complications (OR 0.62 (95 % CI:  
0.61-0.63).  
Table 8 displays the distribution of ASA class by gender. The majority of our study population was 
assigned to an ASA class of three. However, more male had an ASA class of three (47.46%) than the 
female patient population (45.33%). Most of the unknown gender had an ASA class of two (54.17%). 
Patients with an ASA class of five were less likely to undergo surgery and represented less than 1 % of 
the study population.  
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The five most common major complications in this study cohort were ventilator use for ≥48 hours 
(8.99%), wound disruption (2.28%), bleeding requiring ≥ 4 units of red blood cells (1.67%), organ space 
site infection (1.58%), and renal failure (1.35%) within 30 days of surgery. (Table 9)  
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Table 9. Frequency of major postoperative complications 
 
                                     Frequency major complications n= 4,757 (14.37%) 
Major complication 
Ventilator use ≥ 48h                2,977 (8.99%) 
Wound disruption       755 (2.28%) 
≥4 Units red blood cells       554 (1.67%) 
Organ space side infection      524 (1.58%) 
Renal failure        446 (1.35%) 
Death within 30 days       342 (1.03%) 
Sepsis         328 (0.99%) 
Pneumonia        267 (0.81%) 
Unplanned intubation       230 (0.69%) 
SIRS         179 (0.54%) 
Septic shock        165 (0.50%) 
Graft failure        116 (0.35%) 
Myocardial infarction         65 (0.20%) 
Deep venous thrombosis        57 (0.17%) 
Pulmonary embolism         56 (0.17%) 
Stroke           55 (0.17%) 
Cardiac arrest          21 (0.06%) 
Coma ≥24h          21 (0.06%) 
 
4.1.2 Association between surgical Apgar score and major complications 
Table 10 displays the logistic regression results as well as test statistics that determine the overall 
significance of the logistic regression model. The odds of having a major complication are 0.62 times the 
odds of not experiencing a major complication for every one-unit increase in sAs. (OR 0.62 (95 % CI:  
0.61-0.63).  
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Table 10. Binary Logistic Regression Analysis Results 
Predictor  β  Standard Error          Wald χ2            DF                p-value          OR (eβ, 95% CI) 
Constant          1.16            0.06          386.96         1    <0.001          n/a 
sAs                 -0.48            0.01       2,379.41         1    <0.001           0.62 (0.61-0.63) 
Model fit      χ2    DF    p-value 
Overall Model Evaluation                     2,572.00    1   <0.001 
Likelihood Ratio Test  
Score test          2,743.80    1   <0.001 
Wald test          2,379.41    1   <0.001 
DF= Degrees of Freedom 
OR= Odds Ratio  
 
4.1.3 Thirty-day Morbidity and Mortality by surgical Apgar score  
In this study cohort patients were more likely to have an end of case sAs of 7 or 8. Among 2,640 patients 
with a score of 9 or 10, merely 153 patients (5.8%) suffered from major complications within 30 days. In 
comparison, 505 patients with a score of ≤2 279 patients (55.2%) experienced major complications. 
Patients who had a surgical Apgar score between 0-2 had 7.12 times (95% CI, 6.45-7.78) increase in risk 
to suffer from major complications than patients with a score between 7-8. Patients with an end sAs of 9 
or 10 had on the other hand a 0.75 (95% CI, 0.64-0.88) chance of suffering from major complication than 
patients with a score of 7-8. (Table 11) 
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4.1.4 Association between Surgical Apgar Score and Major Complications by Primary 
Service 
Table 12 displays the distribution of patients within each primary service. For every unit increase of the 
sAs the odds of suffering from major complications decreased by almost 40% in General Surgery (OR, 
95% CI: 0.571-0.679) but only decreased by less than 17% in Burn patients (OR, 95% CI: 0.756-0.920). 
In Ophthalmology only two deaths occurred during 30 days; thus there is a significant amount of 
uncertainty in the Odds Ratio.   
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Table 12.  Odds Ratio and Major Complication by Primary Service 
Primary Service  Total  number of complications OR (95% CI)  
Burn    708   235   0.834 (0.756-0.920)∗ 
Emergency   762   274   0.662 (0.601-0.730)∗ 
General oncology            1,795   255   0.584 (0.536-0.637)∗ 
General surgery             1,924   259   0.623 (0.571-0.679)∗ 
Gynecology             2,215     87   0.635 (0.555-0727)∗ 
Head and neck             1,453   197   0.719 (0.639-0.809)∗ 
Liver transplant               717   279   0.574 (0.519-0.635)∗ 
Neurosurgery             3,730   524   0.680 (0.638-0.724)∗ 
Ophthalmology                 72       2   1.498 (0.448-5.006)  
Oral                662   102   0.661 (0.571-0.766)∗ 
Orthopedic             3,570   316   0.703 (0.655-0.755)∗ 
Ortho sports/hand            1,109     84   0.616 (0.531-0.713)∗ 
Orthopedic trauma            4,056   726   0.652 (0.620-0.686)∗ 
Otolaryngology               955     25   0.509 (0.391-0.662)∗ 
Plastic Surgery             1,849    201   0.664 (0.601-0.733)∗ 
Renal                            606     60   0.586 (0.496-0.693)∗ 
Thoracic                           860   141   0.578 (0.511-0.653)∗ 
Trauma                          1,271   591   0.771 (0.726-0.820)∗ 
Urology                         3,785   151               0.588 (0.533-0.649)∗ 
Vascular                         1,009   248   0.609 (0.554-0.670)∗ 
∗Odds Ratio are significant at the ∝ =0.05 
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4.1.5 Variation of surgical Apgar score throughout a surgical case in correlation to major 
complications 
Table 13 shows the relative risk for major perioperative adverse events by categorized mean surgical 
Apgar score (sAs ≤ 4, 4<sAs ≤ 7, sAs>7). Out of all patients who had a complication, 11.50% had a mean 
sAs of ≤ 4 and 60.90% had an intermediate mean sAs (4<sAs ≤ 7). Patients who did not experience a 
complication, 56.35% had a high mean sAs (> 7). The risk of suffering from a complication among 
patients with a high mean sAs (sAs >7) is 61.52% lower than the risk of having an adverse event among 
patients with intermediate mean sAs (4<sAs≤7). The risk of experiencing a complication among patients 
with a low mean sAs (0≤sAs ≤4) is 58.87% higher than that of patients with an intermediate sAs. Patients 
with a lower mean sAs have an increased relative risk of 2.43 (95%, CI: 2.27-2.60) than patients with an 
intermediate sAs. On the other hand, patient with high mean sAs have a 0.38 (95%, CI: 0.36-0.41) 
increased risk in comparison to patients with an intermediate risk. 
78.83% of patients who suffered from a major complication had a sAs decreased throughout the case 
(negative slope). 66.78 % of patients did not suffer from complication and less variation of sAs 
throughout the surgery (positive slope). The percentage of patients whose sAs got worse throughout their 
procedure and who had complications was significantly higher than to patients without outcome 
(p<0.001).  
Patients who experienced postoperatively an adverse event, more than half (51.78%) had a coefficient of 
variation greater than 10 %. Out of all patients who did not suffer from any complication, only 25.97% 
had a greater than 10 % variation of their score during surgery. The greater variation in sAs is 
significantly associated with a higher risk of experiencing a complication.  
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Table 14 displays a multivariate logistic regression model. In cases with a high coefficient of variation 
(CV >10%) throughout the procedure the odds of having a complication were 1.76 (95%, CI, 1.62-1.91) 
times the odds of patients who had a low coefficient of variation (CV≤ 10). Patients with mean sAs of less 
than four had 5.87 (3.63-9.50) the odds of having an adverse event than patient with an intermediate mean 
sAs. If the sAs decreased (negative slope) over the course of a surgery the patient had 1.47 times the odds 
of having a negative outcome than patients where the sAs increased (positive slope) over time. In our 
study the Hosmer-Lemeshow statistic is not significant, indicating that our model fits the data.  
 
49 
 
Table 14. Multivariate Logistic Regression Analysis Results 
Predictor  β  Standard Error          Wald χ2            DF                p-value          OR (eβ, 95% CI) 
Constant          -1.96            0.04          2,358.34         1              <0.001                    n/a 
Slope  0.39            0.04               96.49         1              <0.001              1.47 (1.36-1.59) 
CV  0.56            0.04              175.92         1            <0.001                1.76 (1.62-1.91) 
Low mean   1.77            0.25  51.88         1             <0.001             5.87 (3.63-9.50) 
sAs 
 
mean high    -0.96             0.05             454.45         1             <0.001  0.38 (0.35-0.42) 
sAs 
 
cvhml  -0.83            0.25  10.52         1               0.001   0.44 (0.27-0.72) 
cvhmh  0.22            0.08   7.86         1               0.005  1.25 (1.07-1.46) 
Model fit      χ2    DF    p-value 
Overall Model Evaluation                     2,268.77    6   <0.001 
Likelihood Ratio Test  
Score test          2,514,70    6   <0.001 
Wald test          2,106.86    6   <0.001 
Hoshmer-Lemeshow    5.30    5       0.38 
DF= Degrees of Freedom 
OR= Odds Ratio 
Cv= coefficient of variation with low cv (<10% as reference category) 
χ2= chi2 test 
Slope= reference category is positive slope 
Interaction terms: sncvh= slope negative coefficient variation high; cvhmh=coefficient variation high mean high; cvhml= 
coefficient of variation high mean low; sncvhml=slope negative coefficient of variation high mean low; sncvhmh= slope 
negative coefficient of variation high mean high 
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Figure 3 demonstrates the ability of our logistic regression model to predict adverse events. Overall our 
model has an acceptable level of discrimination between patients with and without major postoperative 
complications with an area under the curve of 0.70. 
 
Figure 3. ROC curve, assessing discriminatory performance using sensitivity and specifity parameters 
 
 
 
Table 15 summarizes odd ratios for different values of our interaction term variables. We performed 
affect modification to determine if the variables in our model are influenced by each other. Patients with 
an intermediate mean sAs and a low coefficient of variation were used as the reference group. Our initial 
model was the largest possible model incorporating sAs slope, mean sAs, and variation of sAs throughout 
the procedure and all possible interaction between each other. 
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We used backwards elimination to determine which interaction terms to keep in our final model. We 
dropped to least significant interaction term one at a time. Patients with sAs variation of >10% but a high 
mean sAs are less likely to experience major complications (OR 0.84, 95% CI, 0.74-0.96) 
 
 
 
4.2 Second part: Surgical Apgar score in general, vascular, oncology surgery 
      
4.2.1 Patient characteristic in general, vascular, and oncology surgery 
In the second part of the study, we obtained complete electronic intraoperative data on 4,728 patients that 
fulfilled our inclusion criteria: 1,924 general surgery patients, 1,795 general oncology patients, and 1,009 
vascular surgery patients. Demographic and intraoperative characteristics of the study population are 
displayed in Table 16, which compares patients with postoperative complications to patients without 
postoperative complications. The overall incidence of major complications within 30 days of surgery was 
16.11% (95% CI, 15.08-17.20), corresponding to a total of 762 patients. Major complications included 71 
deaths (1.50%, 95% CI, 1.17-1.89) within 30 days of surgery. Mean age of the study population was 55.0 
years, with patients suffering from major complications being on average four years older than patients 
without complications (p<0.001). Women represented 53.39% of the study population and were less 
likely to experience major complications than men, 43.70% versus 56.04 %, p<0.001.  Increased patient 
age, higher American Society of Anesthesiologists Physical Status Classification, and longer duration of 
the surgical procedure were associated with a statistically significant increase in adverse events following 
surgery (p<0.001). The lowest intraoperative heart rate was significantly higher (62 versus 56, p<0.001) 
and the lowest mean arterial pressure was significantly lower (49 versus 51, p<0.001) in patients with 
postoperative complications compared to patients without postoperative complications. Patients with 
blood loss exceeding 800 ml were significantly more likely to suffer from adverse events (p<0.001), as 
were patients with a lower surgical Apgar score (p<0.001). For every unit decrease in the surgical Apgar 
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score, the univariate odds of having a major postoperative complication increase by 62% (OR 1.62; 95% 
CI, 1.59-1.65; p<0.001).  
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4.2.2 Thirty-day Morbidity and Mortality by surgical Apgar score in general, vascular, 
and oncology Surgery  
Out of 4,728 patients, 762 (16.11%) experienced one or more adverse events. The five most frequent 
major complications in this study population were ventilator use for more than 48h (27.86%), wound 
disruption (15.03%), deep or organ-space surgical site infection (12.58%), renal failure (10.13%), and 
sepsis (8.25%). 
The association between major postoperative complications and various ranges of surgical Apgar scores 
in the second part of the study is illustrated in Table 17. Approximately half of the patients had an end-of-
case surgical Apgar score of 7 or 8. Among 402 patients with a score of 9 or 10, only 32 patients (8.0%, 
95% CI, 5.51-11.05) suffered from major complications within 30 days of surgery. In comparison, among 
443 patients with a score of ≤ 4, 206 patients (46.5%, 95% CI, 41.78-51.27) experienced adverse events 
postoperatively. Patients who had an end-of-case surgical Apgar scores between 0-4 had almost a five 
times increased risk (Relative Risk [RR] 4.8, 95% CI, 4.4-5.6; p<0.001) of suffering from major 
postoperative complications compared to patients with a surgical Apgar score between 7-8. On the other 
hand, patients with an end-surgical Apgar score of 9 or 10 had a mildly decreased risk (RR 0.9, 95% CI, 
0.6-1.3; p<0.001) of experiencing major complications compared to patients with a score of 7-8.  
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4.2.3 Correlation between the surgical Apgar score and American Society of 
Anesthesiologists physical status classification system 
Figure 4 illustrates the ROC curves for each model and surgical service.  
Figure 4. Receiver Operating Characteristic Curves for Three Surgical Subspecialties 
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Figure 4. Receiver operating characteristic curves for each surgical service and for the pooled cohort were established for each 
risk model investigated. The discriminative value for each model is illustrated by the area under the receiver operating 
characteristic curve (AUROC) cited in the figure. 
 
Table 18 summarizes the discriminative value of each model using the area under the receiver operating 
characteristic curve (AUROC), with 95% bootstrap confidence intervals. In general surgery, the AUROC 
for the ‘ASA’ model is 0.69 compared to 0.71 for the ‘sAs’ model. The ‘HR and ASA’ and the ‘HR, 
MAP, and ASA’ models demonstrated a slightly better predictive ability than the ‘sAs’ model, with an 
AUROC of 0.72 in both models, respectively. Nevertheless, the ‘sAs and ASA’ model results in a 
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superior predictive ability, with an AUROC of 0.74. The bootstrap validated estimate of AUROC for the 
‘sAs and ASA’ model in general surgery cases was 0.74, indicating very little ‘optimism’ due to model 
overfitting (Table 18).  
Table 18. Summary of Areas under the Receiver Operating Characteristic Curve 
 General Vascular Oncology Combined 
sAs and ASA 0.74 (0.73; 0.75) 0.80 (0.78; 0.81) 0.78 (0.76; 0.80) 0.80 (0.79; 0.80) 
ASA 0.69 (0.68; 0.69) 0.73 (0.72; 0.74) 0.71 (0.69; 0.74) 0.73 (0.73; 0.74) 
sAs 0.71 (0.69; 0.72) 0.72 (0.70; 0.74) 0.70 (0.65; 0.74) 0.74 (0.74; 0.75) 
HR 0.67 (0.65; 0.69) 0.68 (0.65; 0.70) 0.70 (0.64; 0.74) 0.66 (0.62; 0.69) 
HR and ASA 0.72 (0.70; 0.73) 0.76 (0.74; 0.77) 0.77 (0.73; 0.79) 0.75 (0.72; 0.77) 
MAP 0.62 (0.59; 0.64) 0.64 (0.62; 0.66) 0.59 (0.55; 0.63) 0.60 (0.57; 0.63) 
MAP and ASA 0.70 (0.68; 0.71) 0.75 (0.72; 0.76) 0.72 (0.69; 0.74) 0.72 (0.70; 0.74) 
HR, MAP, and ASA 0.72 (0.70; 0.73) 0.74 (0.72; 0.76) 0.74 (0.71; 0.77) 0.73 (0.70; 0.75) 
Table 18. summarizes the area under the receiver operating characteristic curve (AUROC) statistics for each model and surgical 
service, with bootstrap 95% confidence interval, demonstrating the discriminative value of each model.  
 
In vascular surgery, the AUROCs for the ‘ASA’ and ‘sAs’ models are similar, with an AUROC of 0.73 
and 0.72, respectively. Even in this specialty the combined ‘sAs and ASA’ model exhibits a better 
predictive ability, with an AUROC of 0.80 (95% CI: 0.78-0.81), which is superior to that of all other 
models. In general oncology the ‘ASA’ model predicts postoperative complications slightly more 
accurately (AUROC 0.71) than the ‘sAs’ model (AUROC 0.70), ‘HR’ model (AUROC 0.70), and the 
‘MAP’ model (AUROC 0.59).  Among all three subspecialities investigated in the study, the 
discriminative value of the ‘sAs and ASA’ model is the strongest in vascular surgery with an AUROC of 
0.80. When all subspecialties were merged, the predictive ability of the ‘sAs’ model (AUROC 0.74) was 
slightly better than that of the ‘ASA’ model (AUROC 0.73). The ‘sAs and ASA’ model (AUROC 0.80) 
remained superior to the ‘HR’ model (AUROC 0.66), the ‘HR and ASA’ model (AUROC 0.75), the 
‘MAP’ model (AUROC 0.60), the ‘MAP and ASA’ model (AUROC 0.72), and the ‘HR, MAP, and ASA’ 
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model (AUROC 0.73).  Calibration curves associated with the ‘sAs and ASA’ model for each surgical 
service at procedure times 0, 60, and 120 minutes (Figure 5) indicate acceptable calibration, especially for 
the most common risk values.  
Figure 5. Calibration curves 
 
Figure 5. The calibration plot compares the model’s predictive ability. The diagonal line represents the ideal situation. The curve 
corresponds to the relation nonparametrically. Calibration curves were constructed for each of the three surgical subspecialties at 
the beginning of each procedure, at 60 minutes, and at 120 minutes. 
Table 19 describes the pairwise comparison of the eight risk models, using ratios (expressed as 
percentages) of the corresponding AUROCs. In particular, the AUROC for the combined ‘sAs and ASA’ 
model was improved by 7.9% (95% CI, 6.3-9.6) relative to the ‘ASA’ model in general surgery cases, 
9.1% (95% CI, 7.1-11.0) in vascular surgery, 10.1% (95% CI, 6.4-13.5) in oncology surgery, and 8.5% 
(95% CI, 7.8-9.4) in the combined cohort. The AUROC for the combined ‘sAs and ASA’ model, relative 
to the ‘sAs’ model, was improved by 4.5% (95% CI, 3.6-5.5) in general surgery, 11.3% (95% CI, 9.4-
60 
 
13.7) in vascular surgery, 12.0 % (95% CI, 7.9-17.2) in oncology surgery, and 7.2% (95% CI, 6.8-7.8) in 
the pooled cohort. In summary, in all three specialties included in this study and in the pooled cohort, 
combining ASA classification with surgical Apgar score trend analysis showed a superior discriminative 
value in comparison to either risk score alone. (Table 19)  
Table 19. Model AUROC Comparison 
General Surgery 
 ASA sAs HR HR and ASA MAP MAP and 
ASA 
HR, MAP, 
and ASA 
sAs and ASA 7.9  
(6.3; 9.6) 
4.5  
(3.6; 5.5) 
10.1  
(7.5; 13.2) 
3.0  
(1.3; 5.0) 
20.4  
(16.4; 25.5) 
6.0  
(3.7; 8.6) 
3.0  
(0.7; 5.8) 
ASA  -3.2  
(-4.6; -1.2) 
2.0  
(-0.5; 5.0) 
-4.5  
(-6.3; -2.5) 
11.5  
(8.3; 16.0) 
-1.8  
(-3.8; 0.5) 
-4.6  
(-6.8; -2.0) 
sAs   5.4  
(2.9; 8.3) 
-1.4  
(-3.4; 0.7) 
15.2  
(11.3; 20.0) 
1.4  
(-1.0; 3.9) 
-1.4  
(-3.8; 1.3) 
HR    -6.3  
(-7.7; -5.3) 
9.3  
(5.4; 13.9) 
-3.7  
(-6.4; 0.8) 
-6.5  
(-8.8; -4.0) 
HR and ASA     16.9  
(12.7; 22.0) 
2.9  
(0.4; 5.6) 
0.0  
(-2.1; 2.4) 
MAP      -11.9  
(-14.3; -10.3) 
-14.4  
(-17.1; -12.2) 
MAP and 
ASA 
      -2.8  
(-4.4; -1.3) 
 
Vascular Surgery 
 ASA sAs HR HR and ASA MAP MAP and 
ASA 
HR, MAP, 
and ASA 
sAs and ASA 9.1 
(7.1; 11.0) 
11.3  
(9.4; 13.7) 
18.6  
(14.9; 23.0) 
5.9  
(3.6; 8.3) 
24.5  
(20.4; 29.8) 
7.5  
(4.5; 10.5) 
8.0  
(4.6; 11.3) 
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ASA  2.1  
(-1.2; 5.6) 
8.8  
(5.5; 12.9) 
-2.9  
(-5.0; -0.42) 
14.1  
(10.3; 18.6) 
-1.4  
(-4.2; 1.4) 
-1.0  
(-4.0; 2.3) 
sAs   6.6  
(2.7; 11.0) 
-4.8  
(-8.1; -1.7) 
11.9  
(7.7; 17.1) 
-3.4  
(-7.1; -0.1) 
-3.0  
(-6.8; 0.5) 
HR    -10.7  
(-12.8; -9.0) 
5.0  
(-0.1; 10.0) 
-9.3  
(-13.2; -5.6) 
-9.0  
(-12.2; -6.0) 
HR and ASA     17.5  
(13.3; 22.3) 
1.5  
(-1.4; 4.5) 
1.9  
(-0.6; 4.6) 
MAP      -13.6  
(-15.9; -11.4) 
-13.3  
(-15.8; -10.7) 
MAP and 
ASA 
      0.4  
(-1.8; 2.7) 
 
 
Oncology Surgery 
 ASA sAs HR HR and ASA MAP MAP and 
ASA 
HR, MAP, 
and ASA 
sAs and ASA 10.1  
(6.4; 13.5) 
12.0  
(7.9; 17.2) 
11.6  
(6.2; 19.9) 
2.0  
(-1.3; 6.5) 
32.6  
(25.5; 40.4) 
8.8  
(4.7; 13.2) 
5.2  
(1.5; 9.7) 
ASA  1.7  
(-3.2; 8.2) 
1.3  
(-4.4; 10.0) 
-7.4  
(-11.0; -2.6) 
20.4  
(15.1; 26.8) 
-1.2  
(-4.7; 3.2) 
-4.4  
(-8.5; 1.1) 
sAs   -0.3  
(-6.0; 6.0) 
-8.8  
(-14.3; -3.3) 
18.5  
(10.0; 25.9) 
-2.7  
(-9.7; 3.1) 
-6.0  
(-12.2; -0.9) 
HR    -8.5  
(-13.0; -5.4) 
19.0  
(9.6; 27.4) 
-2.4  
(-9.9; 4.2) 
-5.6  
(-11.5; -0.8) 
HR and ASA     30.1  
(21.8; 38.2) 
6.7  
(1.9; 11.7) 
3.2  
(-0.1; 6.5) 
MAP      -17.9  -20.6  
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(-21.4; -14.5) (-24.8; -16.2) 
MAP and 
ASA 
      -3.3  
(-6.7; 0.5) 
 
Combined Surgery 
 ASA sAs HR HR and ASA MAP MAP and 
ASA 
HR, MAP, 
and ASA 
sAs and ASA 8.5  
(7.8; 9.4) 
7.2  
(6.8; 7.8) 
20.0  
(14.4; 28.1) 
6.9  
(4.0; 10.8) 
33.2  
(27.7; 40.5) 
10.8  
(7.9; 14.5) 
9.1  
(5.7; 13.0) 
ASA  -1.2  
(-2.2; -0.3) 
10.5  
(5.4; 17.8) 
-1.6  
(-4.3; 2.4) 
22.8  
(17.7; 29.5) 
2.0  
(-0.6; 5.6) 
0.5  
(-2.7; 4.2) 
sAs   11.9  
(6.4; 19.3) 
-0.3  
(-3.2; 3.1) 
24.3  
(18.9; 31.1) 
3.3  
(0.5; 6.8) 
1.8  
(-1.5; 5.6) 
HR    -10.9  
(-14.3; -8.5) 
11.1  
(4.7; 17.3) 
-7.6  
(-13.3; -3.0) 
-9.0  
(-13.7; -5.2) 
HR and ASA     24.7  
(19.1; 30.6) 
3.7  
(0.2; 7.6) 
2.1  
(-0.6; 5.0) 
MAP      -16.9  
(-19.8; -14.2) 
-18.1  
(-21.1; -14.9) 
MAP and 
ASA 
      -1.5  
(-3.6; 1.2) 
Table 19 presents the ratio of the corresponding AUROC values (row/column) as a percentage, with bootstrap 95% confidence 
interval. Positive values indicate that the area under the receiver operating curve corresponding to the model listed in the row 
header was larger than that in the column header. 
 
4.2.4 Notification model 
In order to determine when real-time monitoring surgical Apgar score trends might raise an alarm in 
response to acute changes in a patient’s surgical Apgar score at various threshold probabilities for 
postoperative complications, we calculated the first time when a notification would have been raised for 
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each case in our patient population. Figure 6 displays box and whisker plots for the times to first 
hypothetical intraoperative notifications, at increasing threshold probabilities. At high threshold 
probabilities, alerts are raised later during the surgical procedure. Conversely, alerts are activated earlier 
in the case when the threshold probability is set low since with this low tolerance for postoperative 
complications the threshold is exceeded more readily. A notification criterion based exclusively on the 
ASA classification would have raised a notification either at the very beginning of the procedure or not at 
all since the ASA classification utilizes only preoperative information that does not change throughout a 
procedure. In contrast, utilizing continuously monitored intraoperative factors in addition to ASA 
classification enables notification at any time during the surgical procedure. We believe that this feature is 
largely responsible for gains in sensitivity and specificity. Outliers in Figure 6 may be attributed to a 
paucity of patients who had a high probability of experiencing adverse events. Although threshold levels 
for notification should be optimized and validated in a prospective manner, our findings indicate that a 
threshold probability of 0.24 would exhibit acceptable specificity (0.85) and sensitivity (0.53) while 
maximizing clinical utility and avoiding premature activation.  
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Figure 6. Whisker Plots for Hypothetical Notification Models 
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Figure 6. Displayed are Box and whisker plots for the times to first hypothetical intraoperative 
notification, at increasing threshold probabilities for each surgical service and the pooled cohort.  
 
5 Discussion  
5.1 Implications  
In this study we found that continuous surgical Apgar score measurement combined with static 
demographic and clinical patient data can provide useful information about acute changes in a patient’s 
status and his/her risk for postoperative complications in general, vascular, and general oncology surgery. 
In our study this form of postoperative risk assessment was superior to conventional methods of risk 
stratification. The model was generated in only three surgical services in order to investigate the 
predictive ability of the continuous assessment of sAs for adverse events. General surgery and vascular 
surgery were chosen for our study since the surgical Apgar score had originally been validated in these 
subspecialties. General oncology was chosen due to the large sample size of this patient cohort.  
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Our findings were consistent with previous studies, as we observed that a lower surgical Apgar score was 
associated with a patient’s risk of suffering from major postoperative complications within 30 days 
following surgery.(8, 19, 106)  The score had originally been derived from general and vascular surgery cases, 
(8) and here we have demonstrated that the predictive ability of both morbidity and mortality of the 
surgical Apgar score remains valid in an unselected surgical population. 
In 2011 Reynolds et al. demonstrated that the predictive ability of the surgical Apgar score varies among 
different surgical subspecialties.(120) The score has proven to be applicable in all different specialties.(120) 
However, by calculating the end-of-case sAs in 20 different surgical subspecialties, we demonstrated that 
the association between surgical Apgar score and major complications varies among the subspecialties, 
with Ophthalmology being the only not significant primary service. Due to only two incidences of major 
complication within this service, this leads to a significant amount of vagueness in the Odds Ratio. Odds 
Ratios are ranging from 0.812 to 0.513. The difference of the predictive ability of the sAs between the 
subspecialties might occur due to various reasons, such as diverse comorbidities and different causes of 
death within each surgical service.(115, 120) 
High intra-operative heart rate values, lower mean arterial pressure, and large amount of intra-operative 
blood loss lead to a lower surgical Apgar score. In our study population 55.2% of high-risk patients with a 
low end of case surgical Apgar score of less than 2, a total of 279 patients suffered from major 
complications. In contrast patient with a sAs greater than 9 only 5.8% of patients would suffer from major 
complications. With increasing level of sAs the percentage of major complication would decrease. 
Likewise with decreasing level of surgical Apgar score the rate of major complication would increase.  
After the validation of the end-of-case sAs in this study population, we investigated if surgical Apgar 
score changes throughout a surgical case. At first, we calculated the mean sAs and determined its 
association to major complications. Unexpectedly, the majority of patients who encountered a major 
complication had a mean sAs between 4 and 7. This result demonstrates that the mean sAs might not be 
an accurate predictor of major complication. Subsequently, we evaluated how changing sAs over time 
influences the risk of suffering from major complications. Surprisingly, the Odds Ratio for patients with 
less variation in their sAs and with a low mean sAs was greater than in patients with a great variation and 
low mean sAs. This finding was interesting as the risk for major complication increased among patients 
with a low mean sAs. The results show that patients with great variation or drastic drop in their surgical 
Apgar scores have a greater risk of suffering from major complication. On the other hand, patients with 
relatively stable sAs are less likely to experience adverse events. Some patients with lower end-of-case 
surgical Apgar scores did not have a major complication. This evaluation of sAs trends does not raise a 
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notification or suggest when a clinician should intervene. Systematic changes in surgical Apgar score 
throughout a surgical procedure, as opposed to random or periodic fluctuations, were inversely associated 
with major complications. 
In order to improve the predictive ability of the continuously measured surgical Apgar score, we decided 
to calculate the sAs, whenever new data is available and investigate the predictive ability of the 
continuous surgical Apgar score. We have demonstrated that calculating the surgical Apgar score at 
various time points throughout the procedure, determining the magnitude of drop in surgical Apgar score 
from the previous measurement, and quantifying the time spent at that lower level are all predictive of 
postoperative morbidity and mortality within 30 days after surgery. Furthermore our study extends 
previous work by suggesting that continuous monitoring of surgical Apgar score trends in the surgical 
Apgar score model is useful in predicting postoperative adverse events and might allow clinicians to 
intervene early when significant changes in a patient’s surgical Apgar score are noted intraoperatively. 
We validated continuous surgical Apgar score assessment in general, vascular, and general oncology 
surgery and compared it to the widely used ASA classification. Although we found ASA classification to 
accurately predict major postoperative complications, continuous surgical Apgar score monitoring by 
itself had similar predictive ability.  There may be some advantage to the surgical Apgar score if one had 
to use only one metric, in that it is assigned objectively and can be tracked dynamically, as the case 
progresses. 
We have shown that a continuously monitored surgical Apgar score and its associated derivative factors 
improve on the discriminative value of ASA classification alone, in regard to postoperative morbidity and 
mortality within 30 days after surgery. Combining the ASA classification with the surgical Apgar score 
into the ‘sAs and ASA’ model improves predictive ability in all three surgical specialties, demonstrating 
the highest AUROC of 0.80 in vascular surgery. Even when data from all three subspecialties were 
pooled, the predictive ability was comparable to that of each subspecialty examined separately. 
Additionally we compared the discriminative value of intraoperatively monitored HR and MAP, both 
components of the surgical Apgar score, to that associated with ASA classification alone. The ‘sAs and 
ASA’ model predicts major complications slightly more accurately than the ‘HR and ASA,’ the ‘MAP 
and ASA,’ and the ‘HR, MAP, and ASA’ models. We used bootstrap validation to verify that there was 
little ‘optimism’ in our estimate of the AUROC associated with the ‘sAs and ASA’ model in general 
surgery. Lastly, we identified various time-points throughout the procedure at which the first notification 
would be raised for a sequence of threshold probabilities.  
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A variety of measures and intraoperative variables are used to assess a patient’s condition during a 
surgical case, providing clinicians with an overabundance of perioperative data elements.(140) Owing to 
this large amount of information, real-time notifications have been introduced to analyze data elements, 
enable trend detection, and alert clinicians to abnormal values or a patient’s deteriorating condition.(140) 
Alerting systems using anesthesia information management system data have been implemented into 
hospital settings. These systems have been validated to improve compliance with prophylactic antibiotic 
administration,(141)  support clinicians decision on suitable dispensation of antiemetic medication,(142) and 
the improvement of electronic anesthesia documentation.(143) 
Real-time notifications draw the clinicians’ attention to acute changes that may warrant timely 
intervention to improve patient outcome. Our altering model could be used to identify patients who are at 
a higher risk of experiencing adverse events and are in the need of more postoperative monitoring by 
experienced clinicians. Providing real-time notifications in anesthesia has proven to reduce hospital costs, 
improve patient care, and prevent postoperative complications.(140, 144) Real-time notifications about 
changes in a patient’s surgical Apgar score trend will motivate providers to better allocate postoperative 
resources driven by the patient’s tailored, acute physiology. Consequently appropriate resources can be 
used to improve patient care and this might lower complication rates. 
Ghaferi et al. investigated the variation of mortality rates of patients who experience postoperative 
complications across different hospitals.  This study suggests that hospitals with higher mortality rates 
were unable to rapidly detect and manage complications once they occurred.(145) This study exemplifies 
the fallibility of clinicians’ decision-making. This study shows the need of an objective risk assessment 
that could be used as a communication aid among medical staff regarding the patient’s postoperative level 
of care and severity of illness. The surgical Apgar score could support clinicians in their decision-making 
process and allowing a better use of resources for early identification of postoperative complications.  
The overall goal of this study was to extend the utility of the Surgical Apgar score by developing a new, 
easily computable tool that can support clinical decision making in the operating room based on real-time 
changes in patient status during surgery. By extending utility of the surgical Apgar score from a single 
value computed at the conclusion of a surgical procedure to an objective tool that monitors sAs 
throughout the perioperative process, we expect that this implementation will affect clinical decision-
making and behavior in the operating room. A continuous assessment of the surgical Apgar score may 
represent an objective tool to aid clinicians to support their request for additional diagnostic testing, 
invasive patient monitoring, and ordering transfer to the intensive care unit and modifying medical care.  
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We hypothesize that ultimately a number of more timely interventions in response to changing sAs over 
time may reduce perioperative morbidity and mortality.  
5.2 Comparison to other work 
Our findings were consistent with previous studies, as we observed that surgical Apgar score could 
accurately predict a patient’s risk of suffering from major postoperative complications within thirty days 
following surgery.(8, 19, 106) The score had originally been derived from general and vascular surgery cases 
(8) and here we have demonstrated that the predictive ability of both morbidity and mortality of the 
surgical Apgar score remains valid in an unselected surgical population. The score is adept in identifying 
those patients who are more likely to experience major complications in the postoperative period and may 
thus represent an excellent tool to help guide clinical decisions.  
In a recent study, Hyder et al. examined the predictive ability for major complications of surgical Apgar 
score assessed at various time points within general and vascular surgery. (146) Additionally, the sAs was 
compared to the ASA classification. Five models were established for the calculation of the sAs: The 
score was determined instantaneously, at an interval of 5 and 10 minutes (0-5 minutes, 6-10 minutes, etc., 
or 0-10 minutes, 11-20 minutes, etc.), and overlapping windows of 5 and 10 minutes (0-5 minutes, 1-6 
minutes, etc., or 0-10 minutes, 1-11 minutes, etc.). The result was an increase in sampling intervals of sAs 
calculation improved the predictive ability of the score for postoperative complications and caused a 
better model discrimination. The analysis was not applicable to mortality, as the number of deaths was 
insufficient.(146)  
Our approach differs somewhat from the work of Hyder et al. We investigated the direction of changing 
sAs during a surgical procedure by determining the slope of mean surgical Apgar score. The result of this 
investigation indicated that the direction of the slope was significantly associated with perioperative 
complications. We included more than 4,000 patients and also validated continuous assessment of the sAs 
in general oncology surgery. Thus, our analysis demonstrated statistical significance in predicting major 
complications, including death. One strength of our analysis is the combination of continuously 
monitored sAs with the ASA classification, which demonstrates superior discriminative value than either 
score alone. We assessed the predicative ability for major complications of continuously measured sAs 
combined with the ASA classification by using AUROCs and concluded that our model performs well. 
Lastly, we extended previous studies by establishing a notification model based on risk estimates.  
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5.3 Study limitations 
Our study is limited by the following factors: First, this is a single center study conducted at a major 
academic institution and is restricted to an adult patient population undergoing surgery under general 
anesthesia. The notification protocol was only based on smaller patient cohort who underwent general, 
vascular, and general oncology surgery. Considering that the Vanderbilt University Medical Center draws 
patients from a wide geographic radius, postoperative complications of some patients who sought 
postoperative care elsewhere would not have been captured in the study if these patients were lost to 
follow up with our clinicians. However, 95.2% of the patient cohort included in the study had a follow-up 
visit at this hospital.  
Extensive intra-operative blood loss is known to be associated with major postoperative complications. 
(21) Therefore an accurate measurement of blood loss should be granted within each surgical procedure. 
Until today there is no gold standard in assessing intra-operative blood loss although there are many 
different objective and subjective methods. Mostly the visual estimation of intra-operative blood loss 
underestimates the actual amount.(147) However, the visual estimation is free of cost, fast, and possible at 
any time during the procedure.(123) The estimation of intraoperative blood loss has often been criticized to 
be imprecise and may present a major limitation to the surgical Apgar score.(8, 19) However, the original 
authors argue that the amount of blood loss needed to calculate the score falls into a wide enough range 
based on the surgical Apgar score definition to render accurate assessment of intraoperative blood loss 
possible.(8) The broad grouping of EBL to calculate the sAs (0-100ml, 101-600 ml, 601-1,000ml, >1,000 
ml) are simply within the observer’s range of estimation.(123, 124) Another limitation of the study is the 
exclusion of all patients with only one estimated blood loss recording greater than 100 ml at the end of a 
surgical procedure. However, this allowed us to avoid sudden artificial changes of the surgical Apgar 
score trends at the end of a case where blood loss was not documented as it occurred throughout the 
procedure. With improved documentation practices and real-time recording of blood loss, the lack of EBL 
documentation will become a self-correcting problem.  
Electronic monitoring plays a major role in patient anesthesia care and treatment decision-making 
process. Basic electronic monitoring of a patient has proven to reduce intra-operative mortality and 
adverse events.(148) However, intra-operative data artifacts might occur due to various reasons. Data 
artifacts in heart rate and blood pressure readings may occur due to external interventions. If an arterial 
line is flushed, blood is drawn from the access or during pressure line zeroing falsely high values might 
appear. Moving a patient may also influence heart rate recordings. Non-invasively measured blood 
pressure might also be influenced by a not appropriate size cuff, false positioning of the cuff, leaking cuff, 
and many more factors.(149) 
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Although clinicians are required to correct artificial recordings, flawless documentation is not guaranteed. 
Momentarily clinicians determine whether a vital recording is artificial or correct. Much research has to 
be done to ensure appropriate automated artifact detection filters and signal processing techniques in 
order to ensure an accurate surgical Apgar score calculation.(149) Although extreme values in heart rate 
and mean arterial pressure were excluded, artifactual measurements within these limits might be present. 
Finally, no external validation of our model that we developed was performed. In order to verify the 
benefits of continuous surgical Apgar score assessment further studies have to be performed in a different 
patient population.  
6 Conclusion and future work 
6.1 Summary of findings  
As patients move through the perioperative process, their overall risk for complications may change 
depending on certain events. A number of risk scores have been developed to facilitate rapid assessment 
of patients near and long term outcomes, including the surgical Apgar score. The surgical Apgar score is a 
ten-point risk score assessed at the end of a surgical case. The score predicts major complications within 
thirty days of surgery. The surgical Apgar score is based on intraoperative lowest heart rate, lowest mean 
arterial blood pressure, and estimated blood loss. The risk score was designed to be applied at the end of a 
surgical case. The predictive ability of the end-of-case surgical Apgar score for adverse events was 
previously evaluated in different surgical services and international hospital settings. This study assessed 
if a model based on continuously measured surgical Apgar score can provide clinicians with more 
information about a patient’s changing surgical risk throughout the procedure. We hypothesized that 
evaluating the surgical Apgar score continuously during surgery may identify patients at higher risk for 
complication.  
Surgical patients were retrospectively identified at Vanderbilt University Medical Center. We revalidated 
the surgical Apgar score in our study population and evaluated surgical Apgar score trends in all surgical 
services. Moreover, we identified general, vascular, and general oncology surgical patients who 
constituted the study population for further investigation of continuously monitored surgical Apgar score. 
For our study general surgery and vascular surgery were chosen since the surgical Apgar score had 
originally been validated in these subspecialties. General oncology was chosen due to the large sample 
size of this patient cohort. Logistic regression methods were used to construct a series of predictive 
models in order to continuously estimate the risk of major postoperative complications, and to alert care 
providers during surgery in case the risk exceeds a predefined threshold. Area under the receiver 
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operating characteristic curve was used to evaluate the discriminative ability of a model utilizing a 
continuously measured surgical Apgar score relative to models that use only preoperative clinical factors 
or continuously monitored individual constituents of the surgical Apgar score (i.e. heart rate, blood 
pressure, and blood loss). Area under the receiver operating characteristic curve estimates were validated 
internally using a bootstrap method. 
In our study, we found that continuous surgical Apgar score measurement combined with the established 
ASA classification can provide useful information about acute changes in a patient’s status and his/her 
risk for postoperative complications in general, as well as vascular and general oncology surgery. In our 
study population, the continuously measured surgical Apgar score was predictive for major postoperative 
complications. Hypothetical real-time notifications revealed changes in patient’s surgical Apgar score and 
helped to understand how surgical risk for adverse events changed over the course of a surgical case. This 
form of perioperative risk assessment was superior to conventional methods of risk stratification in our 
study.  
In conclusion, this study will guide the prospective analysis to evaluate the utility of providing a real-time 
assessment of patients’ surgical Apgar score. In the future, real-time notifications might allow for 
detection and mitigation of changes in a patient´s accumulating risk of complications during a surgical 
procedure.  
6.2 Future avenues 
This study sought to lay the groundwork to extend the utility of the surgical Apgar score by developing a 
new, easily computable tool that can support clinical decision-making in the operating room based on 
real-time changes in patient status during a surgical procedure. In a future prospective study we intend to 
investigate the utility of providing the perioperative team with a real-time assessment of the patient’s 
surgical Apgar score. The surgical Apgar score for each patient will be displayed on a screen in the 
operation room and will continuously be recalculated once new data (i.e. heart rate, mean arterial blood 
pressure, blood loss) are documented in the electronic anesthesia record. When the patient’s sAs drops 
precipitously, an automatic alert will inform the clinician about the changing acuity level of the patient.  
With such a study we hope to elicit how continuous assessment of the surgical Apgar score over the 
course of a surgical case will affect clinical decision-making, patient care, and postoperative patient 
outcomes. Transitioning from a calculating a single end-of-case surgical Apgar score value to using an 
objective tool that monitors real-time surgical Apgar score throughout the procedure may enable 
clinicians to understand how surgical risk accumulates and changes over time. Once integrated into the 
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operating room setting, such a tool might help with clinical decision-making. Real-time display of 
surgical Apgar score trends might also lead to a new approach to anesthetic and operative management, 
with earlier medical interventions aimed at stabilizing the patient intraoperatively such as modifying 
ventilation or changing clinicians’ medication and fluids usage.  The evaluation of real-time surgical 
Apgar score trends and knowledge of their trajectory may support clinicians’ request for additional 
diagnostic testing, invasive patient monitoring, ordering transfer to the intensive care unit, and modifying 
medical care. We do not expect the changing score itself to influence the clinician’s decision-making 
process, as the score serves as a surrogate of the patient’s intra- and postoperative condition but does not 
mandate certain changes in treatment. Thus, we hypothesize that more timely interventions in response to 
changing surgical Apgar score over time may reduce perioperative morbidity and mortality.  
 
7 Zusammenfassung 
Die vorliegende Doktorarbeit befasst sich mit der kontinuierlichen Erfassung des Surgical Apgar Scores 
während Operationen. Der Surgical Apgar Score wurde 2007 von Gawande et al. in der Allgemein- und 
Gefäßchirurgie entwickelt, um das Risiko für schwerwiegende Komplikation innerhalb der ersten 30 
Tagen nach dem Eingriff vorauszusagen. Der Score ist ein 10-Punkte-System, basierend auf folgenden 
intraoperativ gemessenen Parametern: niedrigste Herzfrequenz, niedrigster mittlerer Blutdruck und 
geschätzter Blutverlust.  
Der Surgical Apgar Score wird dementsprechend am Ende einer Operation erhoben. Dieser Risikoscore 
wurde bereits in mehreren chirurgischen Fachrichtungen validiert und zeigte unterschiedliche, teilweise 
sehr gute Vorhersagefähigkeit für postoperative Komplikationen.  
Diese Doktorarbeit beschäftigt sich mit der Fragestellung, ob eine kontinuierliche Erfassung des Surgical 
Apgar Scores mehr Informationen über das Risikoprofil eines Patienten bietet. Die Daten, die dieser 
Doktorarbeit zugrunde liegen stammen aus einem Datensatz aller Patienten des 
Universitätskrankenhauses der Vanderbilt Universität, die in den chirurgischen Abteilungen behandelt 
wurden. Insgesamt wurden die perioperativen Daten von 33,108 Patienten untersucht.  
Zuerst wurde der Score in einer retrospektiven Studie in allen chirurgischen Fachrichtungen revalidiert 
und die Trends des wechselnden Scores während einer Operation erstellt. Diese Trendmodelle zeigten, 
dass eine starke Variation und ein starker Abfall des Surgical Apgar Scores statistisch signifikant für 
schwerwiegende Komplikationen während eines Zeitraumes von 30 Tagen sind.  
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Der zweite Teil der Studie bestand darin, dass Patienten, die sich einer allgemein-, gefäßchirurgischen 
oder einer tumorchirurgischen Operation unterzogen hatten, für weitere Analysen des kontinuierlich 
gemessenen Surgical Apgar Scores herangezogen wurden. Für dieses Patientenkollektiv wurden mit Hilfe 
von logistischen Regressionsanalysen drei Hauptmodelle entwickelt wurden. Das erste Model (ASA 
Model) war statisch und beinhaltete den ASA Status, die ethnische Zugehörigkeit, Patientenalter und das 
Geschlecht des Patienten. Das zweite Model (sAs Model) beinhaltete die ethnische Zugehörigkeit, 
Patientenalter und das Geschlecht des Patienten sowie Parameter aus dem kontinuierlich bestimmten 
Surgcial Apgar Score („Baseline“, „maximum drop“ und „insult“). Der Insult stellt eine Multiplikation 
aus dem Integral der maximalen Abfällen des sAs und der Zeit dar. Das dritte Model ist eine Kombination 
des ASA und sAs Modells. Die daraufhin durchgeführte ROC-Analyse bestimmte das „ASA+sAs“ Model 
als das genaueste in der Vorhersage schwerer Komplikationen mit einer AUROC von 0,8 in den 
untersuchten Kollektiven.  
Die vorliegende Arbeit konnte das „ASA+sAs“ Model als gute Methode in der Prädiktion postoperativer 
Komplikationen bestätigen.  
Anhand dieser Modelle wurde ein hypothetisches Benachrichtigungssytem für die Allgemein-, Gefäß- 
und Tumorchirurgie entwickelt, welches anhand von Wahrscheinlichkeiten einen hypothetischen Alarm 
auslöste, sobald der Surgical Apgar Score einen zuvor bestimmten Schwellenwert unterschreitet. Das 
Beste Benachrichtigungssystem arbeitet mit einer Komplikationswahrscheinlichkeit von 24%. Dieses 
System soll eine Vorlage für eine prospektive Studie bieten, in der Warnsysteme während einer Operation 
eingesetzt werden könnten. 
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